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2. ABBREVIATIONS 
 
ACN acetonitrile 
AIDS acquired immunodeficiency syndrome 
ATP adenosine triphosphate 
cDNA complementary deoxyribonucleic acid 
EIA exercise-induced anaphylaxis 
ELISA enzyme-linked immunosorbent assay 
FDEIA food-dependent, exercise-induced anaphylaxis 
GTP guanosine triphosphate 
HMW high-molecular-weight 
HPLC high performance liquid chromatography 
HSA human serum albumin 
IFN interferon 
 IgA immunoglobulin A 
 IgE immunoglobulin E 
 IgG immunoglobulin G 
IL interleukin 
kDa kilodalton 
MW molecular weight 
mRNA messenger ribonucleic acid 
PBMC peripheral blood mononuclear cell 
PBS phosphate-buffered saline 
PCR polymerase chain reaction 
PVDF polyvinyl difluoride 
RAST radioallergosorbent test 
RPMI Roswell Park Memorial Institute 
SDS-PAGE sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
SPT skin prick test 
TBS tris-buffered saline 
TFA trifluoroacetic acid 
Th T helper 
TGF transforming growth factor 
TNF tumor necrosis factor 
tTG tissue transglutaminase 
WDEIA wheat-dependent, exercise-induced anaphylaxis 
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3. ABSTRACT 
Wheat has been increasingly recognized as a cause of food-dependent, exercise-induced 
anaphylaxis, a unique form of allergy where ingestion of a specific food before physical 
exercise triggers anaphylactic reactions. The pathomechanism of this severe allergy remains 
still poorly understood. Wheat is one of the six foods that account for the vast majority of 
food-allergic reactions in children, and inhaled wheat flour is an important cause of baker's 
asthma, a well-known occupational respiratory allergy. Although several wheat allergens 
causing baker's asthma have been characterized, there are only a few studies attempting to 
identify allergens responsible for symptoms after wheat ingestion.  
 
This study identified and purified clinically relevant cereal allergens involved in IgE-mediated 
allergy to ingested wheat. Allergen-specific humoral, cellular, and skin prick test (SPT) 
responses were studied in patients with wheat-dependent, exercise-induced anaphylaxis 
(WDEIA) and in children with challenge-confirmed wheat allergy. IgE-binding cereal 
proteins were detected by immunoblotting, purified by high performance liquid 
chromatography, and identified by N-terminal amino acid sequencing. Serum antibody 
responses to the purified allergens were measured by enzyme-linked immunosorbent assay 
(ELISA), and in vivo reactivity was studied by SPTs. Allergen cross-reactivity was examined 
by immunoblot and ELISA inhibition. Allergen-specific basophil reactivity was assessed by 
histamine-release test and peripheral blood mononuclear cell (PBMC) responses by 
lymphocyte proliferation assay. Allergen-induced cytokine mRNA expression was studied 
with the real-time quantitative PCR. 
 
The study describes a total of 32 adult patients with WDEIA, the largest series of such 
patients reported worldwide. An ethanol-soluble storage protein of the wheat grain, identified 
as ω-5 gliadin (Tri a 19), turned out to be a major allergen in WDEIA. IgE antibodies to 
purified ω-5 gliadin were detected by ELISA and / or SPTs in all 32 patients. On the contrary, 
individuals without wheat allergy and patients with baker's asthma, celiac disease, or urticaria 
did not exhibit IgE against this allergen. Supporting its clinical significance in WDEIA, ω-5 
gliadin induced high histamine release from the basophils of patients with WDEIA. In a group 
of 40 children with atopic dermatitis and suspected wheat allergy, the presence of IgE to ω-5 
gliadin was highly predictive of immediate symptoms on oral wheat challenge. Wheat 
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ingestion elicited clinical symptoms in all 16 children with IgE to ω-5 gliadin. Two of the 18 
children with immediate challenge symptoms, the 8 children with delayed symptoms, and the 
13 challenge-negative children did not have IgE to ω-5 gliadin. IgE ELISA with ω-5 gliadin 
gave a diagnostic specificity as well as a positive predictive value of 100%, and a sensitivity 
of 84% for immediate challenge reactions.  
 
Patients with WDEIA had higher levels of serum IgA antibodies to ω-5 gliadin than 
individuals without wheat allergy, whereas levels of IgG subclass antibodies showed no 
significant differences between the two groups. Rye and barley, but not oats, contained 
allergens cross-reacting with ω-5 gliadin. The purified cross-reactive allergens, identified as 
rye γ-70 and γ-35 secalins and barley γ-3 hordein, bound IgE in over 80% of the WDEIA 
patient sera and elicited positive SPTs in 20 to 67% of the patients. When compared with 
controls without wheat allergy, gliadin stimulation of PBMC of patients with WDEIA elicited 
enhanced proliferative responses along with clearly decreased mRNA expression of the anti-
inflammatory cytokine IL-10. The IgE-binding ability of ω-5 gliadin was retained after pepsin 
digestion, and treatment of the digested peptides with tissue transglutaminase (tTG), a cross-
linking enzyme in the intestinal mucosa, formed high-molecular-weight complexes showing 
strong IgE binding in immunoblotting. tTG treatment of a purified peptic fraction of ω-5 
gliadin caused a significant increase in the SPT and IgE ELISA reactivity of patients with 
WDEIA. 
 
In conclusion, the large series of patients reported in the current study suggests that the 
prevalence of WDEIA may be higher than previously assumed. The results presented support 
the clinical practice of a gluten-free diet, though oats seem harmless for patients with 
WDEIA. SPT with a gliadin preparation can be used for screening of WDEIA, and SPT or 
ELISA with ω-5 gliadin for the specific diagnosis of this severe food allergy. Detection of ω-
5 gliadin-specific IgE may be useful in reducing the need for oral wheat challenges in young 
children at high risk for severe allergic reactions. The study confirmed the importance of IgE 
in the pathogenesis WDEIA. In addition, aberrantly regulated cell-mediated responses to 
gliadin seem to play a role. Finally, it is hypothesized that tTG could be activated during 
physical exercise in the intestinal mucosa of patients with WDEIA. tTG-mediated cross-
linking of ingested ω-5 gliadin peptides could create large allergen complexes with numerous 
IgE-binding epitopes capable of eliciting anaphylactic reactions in patients with WDEIA. 
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4. INTRODUCTION 
 
Allergy forms a major health problem in most Western countries; about 20% of the 
population suffer from allergic diseases, such as rhinitis, asthma, atopic dermatitis, and food 
allergy. The prevalence of these diseases has increased significantly over the past few 
decades, but the reason for this increase is incompletely understood (Åberg et al. 1995, von 
Mutius et al. 1998, Linneberg et al. 2000, Krause et al. 2002). According to the "hygiene 
hypothesis", better standards of living and a decline in childhood infections may contribute to 
the marked increase in allergies (Yazdanbakhsh et al. 2002).  
 
The prevalence of food allergy in the general population ranges from 1 to 2% in adults 
(Young et al. 1994, Schäfer et al. 2001) to 6 to 8% in children (Bock 1987). Wheat allergy 
reflects well the diversity of food-allergic diseases, as it encompasses several disorders with 
different pathomechanisms and clinical manifestations. Wheat is among the six foods that 
account for about 90% of food allergies in infants and small children (Sampson and Albergo 
1984), manifesting as skin, gastrointestinal, or respiratory symptoms of immediate or delayed 
onset (Sicherer 2000). In adults wheat is a frequently documented cause of food-dependent, 
exercise-induced anaphylaxis (FDEIA) (Kushimoto and Aoki 1985, Guinnepain et al. 1996, 
Varjonen et al. 1997), a life-threatening allergy where ingestion of a specific food before 
physical exercise triggers severe anaphylaxis (Kidd et al. 1983). Furthermore, inhaled wheat 
proteins are a major cause of baker's asthma, a well-known occupational respiratory allergy to 
inhaled flour (Baur et al. 1998). 
 
Several wheat allergens have been identified and characterized in baker's asthma (Baur and 
Posch 1998), but allergens responsible for wheat-dependent, exercise-induced anaphylaxis 
(WDEIA) remain largely unidentified. The immunopathologic mechanisms underlying this 
severe food allergy are as well unknown. Although allergens in many of the major foods 
causing allergies in children (i.e., milk, egg, soy, and peanut) have been identified and studied 
extensively (Sicherer and Sampson 1999), very little is known about clinically relevant wheat 
allergens.  
 
Limited knowledge on clinically significant allergens has made difficult the development of 
accurate diagnostic tests for wheat allergy. At present, the diagnosis of food allergy is based 
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on the patient's clinical history, the presence of food-specific IgE antibodies and the results of 
elimination diets and oral challenges (Sicherer 2002). The most frequently used diagnostic 
tests are the radioallergosorbent test (RAST), which detects specific IgE antibodies in serum, 
and the skin prick test (SPT), which measures in vivo IgE reactivity to the tested food 
(Sampson 1999b, Yunginger et al. 2000).  In the case of wheat, the diagnostic accuracy of 
both tests is poor (Sampson and Ho 1997, Sampson 2001). Elimination diets followed by oral 
challenges are therefore often needed to confirm the diagnosis, especially when chronic 
diseases, multiple food allergies, or non-IgE-mediated mechanisms are involved (Sicherer 
1999). 
 
This study aimed to identify, purify, and characterize clinically significant allergens involved 
in IgE-mediated allergy to ingested wheat in adults with WDEIA as well as in children with 
challenge-confirmed wheat allergy. Further aims were to characterize cross-reactive allergens 
in taxonomically closely related cereals, and to investigate allergen-specific cellular immune 
responses of patients with WDEIA. In addition, the study aimed to examine the effects of 
gastrointestinal mucosal enzymes on purified wheat allergens in WDEIA.  
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5. REVIEW OF THE LITERATURE 
5.1 Allergy and atopy 
Hypersensitivity reactions are inappropriate responses of the body to environmental antigens 
triggered via immunologic or non-immunologic mechanisms. Allergy is defined as a  
"hypersensitivity reaction initiated by immunologic mechanisms" and it can be mediated by 
specific antibodies and cells of the immune system (Johansson et al. 2001). Antibodies of the 
immunoglobulin E (IgE) isotype are the most frequent mediators of the immediate allergic 
reaction. This type of allergy is referred to as IgE-mediated or type I allergy. Type IV allergy 
encompasses delayed-type hypersensitivity reactions mediated by antigen-specific T cells 
(Coombs and Gell 1963). The term atopy is defined as a tendency of an individual to produce 
allergen-specific IgE antibodies on exposure to environmental allergens and to develop 
typical allergic symptoms (Coca and Cooke 1923, Johansson et al. 2001). 
 
5.2 IgE-mediated allergy 
5.2.1 Allergens 
In type I allergy, antigens able to induce the immune system to produce IgE antibodies (i.e., to 
sensitize) and to elicit an allergic reaction (i.e., to trigger symptoms in a sensitized individual) 
are called allergens (Aalberse 2000). Typical allergens are proteins or glycoproteins with 
molecular masses ranging from 3 to 80 kilodaltons (kDa), but there is no single structural, 
functional, or chemical property that will define a protein as allergenic. Individual allergens 
are termed major allergens, when they bind IgE antibodies from more than 50% of sera from a 
panel of exposed and sensitized individuals (Liebers et al. 1996). More than 200 allergens 
have so far been identified and characterized. Allergens are designated according to the 
taxonomic name, so that the first three letters of the genus are followed by the first letter of 
the species and an Arabic number that identifies the order of identification (Official list of 
allergens, IUIS Allergen Nomenclature Subcommittee, http://www.allergen.org). 
 
Allergen cross-reactivity is a phenomenon where IgE antibodies recognize similar structures 
on different proteins that are often taxonomically closely related or represent evolutionary 
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conserved structures. Allergens that show in vitro cross-reactivity by binding serum IgE 
antibodies do not, however, always elicit clinical symptoms (Aalberse et al. 2001). 
 
5.2.2 Immunoglobulin E  
IgE was described in 1967 as the fifth immunoglobulin isotype (Ishizaka and Ishizaka 1967, 
Johansson and Bennich 1967). As all immunoglobulins, the IgE molecule is a Y-shaped 
glycoprotein consisting of two identical light chains and two identical heavy chains held 
together by disulfide bonds. Each chain contains variable and constant regions composed of 
globular domains. The variable domains of the heavy and light chains form together the 
antigen-binding site, and the heavy chain determines the antibody isotype (Janeway et al. 
2001). 
 
IgE differs from other antibody classes by its short half-life and very low serum 
concentrations ranging from 50 to 300 ng/ml in normal individuals (Sutton and Gould 1993). 
Despite the low circulating levels, IgE is biologically extremely active. This is because IgE 
exists primarily in a cell-bound state: IgE molecules bind to high-affinity receptors (FcεRI) 
abundantly present on the surface of mast cells and basophils, the effector cells of allergy that 
function in initiating immediate allergic responses (Novak et al. 2001). In addition, antigen-
presenting cells, including monocytes, circulating dendritic cells, and epidermal Langerhans 
cells, express variable amounts of FcεRI (Bieber et al. 1992, Wang et al. 1992). Expression of 
this high-affinity receptor is enhanced in the lesional skin of atopic dermatitis patients and 
correlates with serum IgE levels. Preferential uptake and presentation of IgE-bound allergens 
by epidermal Langerhans cells via FcεRI is considered important in the induction of delayed-
type hypersensitivity reactions and skin inflammation in atopic dermatitis (Reich et al. 2001, 
Novak et al. 2003). Low-affinity receptors for IgE (FcεRII, also known as CD23) are present 
for instance on B cells, monocytes, and dendritic cells (Novak et al. 2001). IgE can augment 
humoral and cellular responses to allergens via the low-affinity receptor CD23, as well as 
upregulate the expression of its own receptors FcεRI and CD23 (Oettgen and Geha 1999). IgE 
is also involved in immunity against parasitic infections. Serum IgE levels rise in parasitic 
diseases, though high IgE levels are most frequently linked with atopic disease in 
industrialized countries (Yazdanbakhsh et al. 2002). 
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5.2.3 Induction of the IgE response  
Activation of T helper lymphocytes 
 The immune response is traditionally divided into humoral and cellular responses. Humoral 
responses emphasize the distinct effects of secreted antibodies, while cellular responses focus 
on the contribution of various effector cells. Among many cells of the immune system, T 
lymphocytes have a central role in orchestrating both cellular and humoral responses to 
allergens (Janeway et al. 2001). These circulating immune cells are important sources of 
cytokines, small hormonal messengers that mediate many functions of the immune system. T 
lymphocytes expressing the cell surface molecule CD4 are also known as T helper cells, 
which can be divided into T helper 1 (Th1) and T helper 2 (Th2) subsets according to the 
profile of secreted cytokines. Th2 cells secrete cytokines that promote eosinophil- or IgE-
mediated allergic inflammation, whereas Th1 cells secrete cytokines that predominantly 
activate intracellular and antimicrobial defenses (Abbas et al. 1996, Romagnani 2000a).  
 
In order to be activated, naive CD4+ T cells must recognize allergens as peptide fragments 
bound to class II molecules of the major histocompatibility complex on the surface of antigen-
presenting cells. Professional antigen-presenting cells include blood and tissue dendritic cells 
as well as cells from the monocyte-macrophage system. Upon first encounter, antigen-
presenting cells take up and process allergens and migrate to regional lymph nodes, where 
they initiate the activation of naive T cells (Bubnoff et al. 2001). When naive T cells 
recognize antigens processed by antigen-presenting cells, they proliferate and differentiate 
into antigen-specific effector cells. This differentiation can occur via two separate pathways 
into either Th1 or Th2 cells. One of these cell types tends to dominate the immune response. 
Cellular immunity dominates Th1-type immune responses promoted by bacterial and viral 
infections, whereas allergens evoke a Th2-type immune response. Upon re-exposure to the 
allergen Th2 cells secrete cytokines, including IL-4 and IL-13, which are the most important 
inducers of IgE production, and IL-5, which promotes eosinophil growth and differentiation. 
The major cytokines secreted by activated Th1 cells are IFN-γ and IL-2, which mobilize 
defense mechanisms against intracellular pathogens and suppress IgE synthesis (Romagnani 
2000b). A delicate balance between these two responses is needed to prevent the development 
of pathologic conditions, such as allergy. Distinct cell populations, i.e., regulatory T cells, 
have been shown to regulate the development of Th1 and Th2 immune responses. These 
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immunosuppressive T cells include type 1 regulatory T cells (Tr1) secreting high levels of IL-
10, type 3 T cells (Th3) that secrete TGF-β, and CD4+CD25+ T cells. They inhibit immune 
responses through cell-cell contact (McGuirk and Mills 2002). Recent evidence suggests that 
an anti-inflammatory network, characterized by elevated levels of the anti-inflammatory 
cytokines IL-10 and TGF-β, balances the expression of Th1 and Th2 responses. When this 
balance is disturbed, aberrantly regulated Th1 responses could lead to autoimmunity and Th2 
responses to allergy (Yazdanbakhsh et al. 2002). 
 
IgE production by B cells  
Upon encounter with an allergen, B cells proliferate and differentiate into antibody-secreting 
cells. Initially all B cells produce antibodies of the IgM isotype. Two distinct signals provided 
by Th2 cells can induce an isotype switch, where B cells alter the immunoglobulin isotype, 
whilst retaining their antigenic specificity. The key signal for isotype switch to IgE is 
mediated by the Th2-derived cytokines IL-4 and IL-13. The second signal is through CD40, a 
molecule expressed on the B cell surface after antigen recognition (Corry and Kheradmand 
1999, Oettgen 2000). This shifting of antibody class synthesis from IgM to allergen-specific 
IgE is known as sensitization. Allergen-specific IgE antibodies produced by B cells bind to 
high-affinity IgE receptors (FcεRI) on the surface of effector cells, such as basophils and mast 
cells. 
 
Activation of mast cells and basophils  
The immediate allergic response arises when the sensitizing allergen cross-links at least two 
IgE antibodies bound to the high-affinity receptors FcεRI on mast cells or basophils. This 
results in a signal cascade that triggers the immediate degranulation and release of preformed 
mediators, such as histamine and tryptase, and shortly thereafter the release of newly formed 
lipid mediators, including leukotrienes, prostaglandins, platlet-activating factor, cytokines, 
and chemokines. These mediators are responsible for the symptoms of the acute allergic 
response as well as for those of late-phase responses (Platts-Mills 2001).  
 
5.2.4 Clinical manifestations 
Immediate responses 
Immediate allergic symptoms begin within minutes after exposure to the allergen. Histamine, 
prostaglandins, and other preformed or rapidly synthesized mediators cause a rapid increase in 
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vascular permeability and the contraction of smooth muscle. The clinical symptoms depend 
on the allergen dose, the amount of allergen-specific IgE, the route of exposure, and the site of 
mast cell activation (Janeway et al. 2001). Allergic responses to inhaled allergens, such as 
pollen or house dust mite, typically involve the mucous membranes of the respiratory tract 
and eyes. Edema and irritation of the nasal or conjunctival mucosa lead to allergic rhinitis or 
conjunctivitis. Bronchoconstriction, increased mucus production, and airway inflammation 
cause the wheezing and cough in asthma. An acute allergic reaction of the skin is 
characterized by an urticarial wheal and flare reaction. Ingested food allergens typically cause 
gastrointestinal and cutaneous symptoms, including vomiting, diarrhea, pruritus, urticaria, and 
erythema (Janeway et al. 2001).  
 
The ultimate manifestation of IgE-mediated allergy is systemic anaphylaxis. Allergens, e.g., 
drugs that enter the body through the bloodstream or food allergens that are rapidly absorbed 
from the gut, can activate the connective tissue mast cells of the entire circulatory system. 
Disseminated mast cell activation causes a widespread increase in vascular permeability, 
generalized erythema, urticaria and angioedema, airway constriction, tracheal occlusion, 
nausea, diarrhea, and abdominal pain. Cardiovascular manifestations may include arrhythmias 
and a dramatic fall in the systemic blood pressure leading to circulatory collapse and death 
(Nicklas et al. 1998).  
 
Late-phase responses 
Immediate responses can be followed by a more sustained inflammation, known as the late-
phase response, which develops 4 to 12 hours after allergen exposure. IgE-mediated 
activation of mast cells leads to an inflammatory cascade mediated by leukotrienes, cytokines, 
and chemokines, which activate and recruit eosinophils, basophils, and Th2 lymphocytes to 
the site of inflammation (Janeway  et al. 2001). Late-phase responses manifest in the skin as 
slightly indurated edema, in the nasal mucosa as congestion and sustained blockage, and in 
the lungs as recurring bronchoconstriction and further wheezing (Kay 2001). If allergen 
exposure continues, the late-phase response can progress into chronic allergic inflammation 
characterized by the presence of effector T cells and eosinophils. Typical examples are 
chronic asthma and worsening of atopic dermatitis  (Janeway  et al. 2001).  
  
 
15 
5.3 Delayed-type allergy 
Delayed or type IV allergic reactions, mediated by antigen-specific Th1 cells, take 
approximately 24 to 48 hours to develop. A classic example is the local cutaneous reaction 
caused by antigen injection into the skin. First, local antigen-presenting cells take up, process, 
and present antigens to Th1 effector cells. Activated Th1 cells secrete chemokines and 
cytokines (e.g., IFN-γ, TNF-α, and TNF-β) that activate local endothelial cells and recruit 
inflammatory cells, mainly macrophages, to the site of antigen deposition. Antigen 
presentation by macrophages causes further activation of Th1 cells, which amplifies the 
inflammatory response. This leads to accumulation of fluid and protein to the site of 
inflammation, leading to erythema, induration, and dermatitis. Another example of type IV 
allergy is allergic contact dermatitis, where the sensitizing agent is a small molecule that 
penetrates easily the skin and binds often to a carrier molecule, before being processed by 
epidermal Langerhan's cells and presented to effector Th1 cells. Celiac disease represents type 
IV hypersensitivity to dietary antigens. Ingested gluten proteins in wheat, rye, or barley elicit 
a Th1-mediated chronic intestinal inflammation characterized by villous atrophy and 
malabsorption (Kay 1997, Janeway  et al. 2001).  
 
5.4 Immune responses to dietary antigens 
Oral administration of soluble antigen induces antigen-specific systemic immune tolerance, 
known as oral tolerance. It is an active immunologic response to harmless ingested antigens 
that leads to life-long tolerance to ingested food antigens and the bacterial flora of the gut. 
Sensitization to dietary antigens and the subsequent development of food allergy is thought to 
represent a failure in the induction or maintenance of oral tolerance (Strobel and Mowat 
1998). 
 
In healthy individuals, the appearance of serum antibodies of the IgM, IgA, and IgG isotypes 
to foods is a normal physiological response to food ingestion. Transient and low levels of 
food-specific IgE may also be detected in early childhood (Husby 2000). Food-specific 
antibody secretion by activated B cells occurs locally in the gastrointestinal mucosa or in the 
circulation. Th2 cytokines and TGF-β are key factors in isotype switching to IgA (Simecka et 
al. 1998, Nagler-Anderson 2001), whereas IL-4, IL-10 and IL-13 cytokines are involved in 
isotype switching to IgG subclasses (Tangye et al. 2002). Food-specific T cell responses, 
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assessed by lymphocyte proliferation and cytokine production, seem to be low in the 
circulation of healthy individuals. Generally the production of cytokines by food-specific T 
cells is higher locally in the gastrointestinal mucosa than in the circulation (Husby 2000). 
 
The IgG response to foods is mainly restricted to the IgG1 and IgG4 subclasses (Duchen et al. 
1997). Although no significant differences in IgG levels have been documented between 
allergic and non-allergic individuals, children with food allergy tend to have higher IgG1 and 
IgG4 levels to common dietary antigens. Increased levels have been correlated with the 
appearance of IgE antibodies to inhalant allergens in later life (Calkhoven et al. 1991, Eysink 
et al. 2002). IgA is the major immunoglobulin at mucosal surfaces, where it exists in a 
dimeric secretory form. Its main function is to protect against infectious or toxic agents. In 
serum, IgA exists in a monomeric form, constituting 15 to 20% of serum immunoglobulins. 
The biological function of serum IgA is, however, incompletely understood (Macpherson et 
al. 2001). With the exception of IgA antibodies to wheat gliadin in celiac disease, serum IgA 
antibodies to foods occur as a part of the normal immune response (Barnes 1995). 
 
5.5 Food allergy 
Food allergy is an adverse immunologic reaction to food. All other food-induced adverse 
reactions are defined as non-allergic food hypersensitivity. IgE-mediated food allergy is by 
definition mediated by IgE antibodies. The term non-IgE-mediated food allergy is 
recommended, when other immunologic mechanisms are involved (Johansson et al. 2001). 
 
5.5.1 Prevalence  
Perceived adverse reactions to foods are common, yet the prevalence of actual food allergy is 
unknown. In the European Community Respiratory Health Survey involving 15 different 
countries, the prevalence of self-reported food hypersensitivity was 12%. It varied 
significantly ranging from 4.6% in Spain to 19.1% in Australia (Woods et al. 2001). An 
epidemiologic survey involving 33 110 persons in France gave a prevalence of 3.2% for self-
reported food hypersensitivity (Kanny et al. 2001). Other community-based studies in the 
UK, Holland, USA, Sweden, Australia, and Germany have reported prevalences between 12 
and 25% (Young et al. 1994, Janssen et al. 1994, Altman and Chiaramonte 1996, Björnsson et 
al. 1996, Woods et al. 1998, Schäfer et al. 2001). However, double-blind, placebo-controlled 
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food challenges confirm the presence of true food allergy only in a small proportion of 
patients with perceived adverse reactions (Bock 1987, Young et al. 1994, Janssen et al. 1994, 
Woods et al. 2002). In adults the estimated prevalence of IgE-mediated food allergy ranges 
from 1 to 2% (Young et al. 1994, Jansen et al. 1994), and in children from 6 to 8% (Bock 
1987). In a subgroup of children with moderate to severe atopic dermatitis, the prevalence of 
food allergy is as high as 30 to 40% (Eigenmann et al. 1998). 
 
5.5.2 Foods causing allergies in children and adults 
Cow's milk, eggs, wheat, soy, peanut, and fish account for about 90% of documented food 
allergy in infancy and early childhood (Sampson and Albergo 1984, Burks et al. 1998, 
Niggemann et al. 1999, Sicherer et al. 2000), and peanut, tree nuts, and seafood for 85% of 
severe reactions in older children and adults (Sampson 1999a, Sicherer and Sampson 1999). 
Fresh fruits and vegetables are a common cause of allergic symptoms especially in relation 
with pollen or latex allergy (Ortolani et al. 1988, Mikkola et al. 1998, Asero 1999).  This type 
of food allergy is due to allergen cross-reactivity; IgE antibodies against pollen or latex 
proteins bind to homologous structures on food proteins.  
 
Most known food allergens are water-soluble, heat-stable glycoproteins with molecular 
masses between 10 and 70 kDa (Lehrer et al. 1997). Resistance to degradation, i.e., the 
stability of the IgE-binding epitope to enzymatic digestion in the gastrointestinal tract, is 
considered a prerequisite (Astwood et al. 1996). Food allergens include proteins with diverse 
biological functions, such as enzymes, storage proteins, and enzyme inhibitors. The majority 
of plant-derived allergens belong to several distinct protein families, which include the 
pathogenesis-related proteins, lipid transfer proteins, seed storage proteins, and profilins 
(Breiteneder and Ebner 2000). Panallergens, such as the profilins in birch pollen, hazelnut, 
and apple; the class 1 chitinases in banana, avocado and latex; and the lipid transfer proteins 
in apple and peach, represent structures conserved across species (Asero et al. 2001). Some of 
the major allergenic food proteins identified and characterized at the molecular level are 
compiled in Table 1 (Official list of allergens, IUIS Allergen Nomenclature Subcommittee, 
http://www.allergen.org). 
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Table 1.  Characterized food allergens 
Food (source) Allergen  Protein function 
Cow's milk Bos d 4 α-lactalbumin Ca2+ binding  
 Bos d 5 β-lactoglobulin Retinol binding  
 Bos d 8 αs-, β-, and κ-caseins Ca2+ binding  and transfer 
Hen's egg Gal d 1 Ovomucoid Serine protease inhibitor 
 Gal d 2 Ovalbumin Non-inhibitory serpin 
 Gal d 3 Ovotransferrin Iron transport  
Peanut Ara h 1 Vicilin Seed storage  
 Ara h 2 Conglutin Seed storage  
 Ara h 3 Glycinin Seed storage  
Soybean Gly m 1 β-Conglycinin Seed storage  
 Gly m 2 Glycinin Seed storage  
Fish Gad c 1 Parvalbumin Ca2+ binding  
Shrimp Pen a 1 Tropomyosin Ca2+ binding  
Hazelnut Cor a 1 Bet v 1 homologue Pathogenesis-related protein 
Brazil nut Ber m 1 2S albumin Seed storage  
Walnut Jug r 1 2S albumin Seed storage  
Mustard Sin a 1 2S albumin Seed storage  
Celery Api g 1 Bet v 1 homologue Pathogenesis-related protein 
 Api g 2 Profilin Actin binding, signal transduction 
Potato Sol t 1 Patatin Storage  
Apple Mal d 1 Bet v 1 homologue Pathogenesis-related protein 
 Mal d 2 Thaumatin-like protein Antifungal  
Peach Pru p 3 Lipid transfer protein Lipid metabolism 
Wheat  α-amylase inhibitor Protease inhibitor 
Barley Hor v 15 α-amylase inhibitor Protease inhibitor 
Maize Zea m 14 Lipid transfer protein Lipid metabolism 
Avocado Pers a 1 Type 1 chitinase Pathogenesis-related protein 
 
 
5.5.3 Digestion and absorption of food allergens 
Ingested food proteins enter the body via the mucosal surface of the gastrointestinal tract. It 
consists of a loose, richly vascularized connective tissue (lamina propria) covered by a single 
layer of epithelial cells, mainly enterocytes, joined together by tight junctions. This epithelial 
barrier restricts the passage of macromolecules from the intestinal lumen to the underlying 
lamina propria (DeSesso and Jacobson 2001). Before crossing the epithelial barrier, most food 
proteins are digested into nonantigenic peptides and amino acids by various enzymes, 
including pepsin in the stomach, trypsin, chymotrypsin, and elastase in the duodenum, and 
lysozomal enzymes inside the enterocyte. Small amounts of proteins and peptides are, 
however, transported intact. The major route for antigen transport is transcytosis, i.e., active 
transport via receptor-mediated endocytosis through the enterocyte. In addition, molecules 
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can pass paracellulary through the tight junctions between the enterocytes (Walker and Bloch 
1983, Heyman 2001). A third route of transport is endocytosis through M cells, specialized 
epithelial cells that play an important role in the induction oral tolerance (Nagler-Anderson 
2001). Food allergy has been associated with epithelial barrier dysfunction, allowing 
immunologically active food allergens to gain access to the circulation. Immaturity of the 
mucosal barrier function favors the development of food allergy in young children (Sampson 
1999a). Experimental models have shown that IgE antibodies bind to low affinity receptors 
(CD23) present on enterocytes, accounting for an enhanced, specific epithelial transport 
system for food allergens in sensitized mice (Yang et al. 2000, Yu et al. 2001). 
 
Early studies on passively sensitized individuals showed that ingested food allergens 
penetrate the gastrointestinal mucosa and enter the circulation, which conveys them 
throughout the body, for example to the skin (Walzer 1927, Brunner and Walzer 1928). Later 
studies on children with IgE-mediated food allergy demonstrated that provocation of 
symptoms by oral food challenges was accompanied by elevations in plasma histamine levels 
and activation of plasma eosinophils (Sampson and Jolie 1984, Suomalainen et al. 1994). 
 
5.5.4 Clinical manifestations  
The clinical manifestations of food allergy comprise a wide range of immediate and delayed 
symptoms affecting the skin, the respiratory and gastrointestinal tracts, and in severe cases the 
cardiovascular system. These diverse manifestations can localize to the site of allergen contact 
or they can be systemic occurring in different organs (Sicherer 2000).  
 
Skin manifestations are the most frequently encountered systemic symptoms. Immediate 
symptoms are mediated by IgE antibodies, and include urticaria, angioedema, and sudden 
erythema. Delayed skin symptoms manifest as exanthema or exacerbation of atopic dermatitis 
(Werfel 2001). The exact mechanisms underlying delayed skin reactions are not fully 
understood, but evidence suggests that specific T cells and IgE, via its high affinity receptor 
FcεRI on epidermal Langerhans cells, are involved (Bieber et al. 1992, Wang et al. 1992, 
Reekers et al. 1996). Although isolated respiratory symptoms to ingested food allergens are 
uncommon, sneezing, rhinorrhea, nasal congestion, wheezing, and cough often accompany 
cutaneous and gastrointestinal reactions (James et al. 1994). Systemic anaphylaxis, the most 
severe manifestation of food allergy, is discussed separately. 
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Local reactions are elicited by direct allergen contact in the oral or gastrointestinal mucosa, 
the skin, or in the case of inhalant food protein allergy the respiratory mucosa (Sicherer 2000). 
Symptoms localized to the oropharynx are known as the oral allergy syndrome, and include 
pruritus and angioedema of the lips, tongue, throat, and palate.  These symptoms usually 
appear and resolve rapidly (Ortolani et al. 1988, Asero 1999). The oral allergy syndrome 
affects about 40% of patients with pollen allergy; the causative food allergens present in fresh 
fruits, vegetables, and tree nuts are mostly unstable and denatured by heat treatment (Eriksson 
et al. 1982, Bircher et al. 1994). In the lower gastrointestinal tract, acute IgE-mediated 
reactions typically cause nausea, abdominal pain, and colic, but may also manifest as severe 
vomiting and diarrhea. Contact urticaria following handling of food proteins is a typical 
example of a localized skin reaction, while inhalation of food allergens, such as cereal flours, 
may cause acute rhinitis, wheezing, and asthma (Sicherer 2000). 
 
5.5.5 Diagnosis and treatment  
The diagnosis of food allergy is based on a detailed clinical history, physical examination, 
detection of food-specific IgE antibodies, and elimination diets followed by oral food 
challenges (Sampson 1999b). The most widely used diagnostic test for IgE detection is the 
SPT, where the allergen extract or fresh food material is punctured into the epidermis with a 
sharp lancet. In the presence of specific IgE, the allergen cross-links two IgE molecules on the 
surface of cutaneous mast cells, and subsequent degranulation and mediator release causes a 
localized wheal and flare reaction within 15 minutes. The RAST is the most common in vitro 
test for measuring serum IgE antibodies. Patient serum is incubated with the desired allergen 
bound to a solid-phase matrix, then IgE binding to the allergen is detected with a secondary 
labeled antibody specific for IgE (Yunginger et al. 2000).  
 
SPTs and RASTs measure sensitization, the presence of allergen-specific IgE, which does not 
necessarily correlate with clinical reactivity. The relevance of each test result should thus be 
interpreted in the context of the patient's history. The RAST is generally less sensitive than 
the SPT, but is useful if the patient is on antihistamine medication or the condition of the skin 
does not allow skin testing. The positive predictive values of these tests are only around 50%, 
whereas their negative predictive values are high, over 95% (Sampson and Albergo1984, 
Sampson and Ho 1997, Sicherer et al. 2000, Sporik et al. 2000, Sampson 2001). A convincing 
history of an immediate allergic reaction after ingestion of an isolated food together with clear 
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positive SPT responses or high concentrations of food-specific IgE may suffice to confirm the 
presence of IgE-mediated food allergy. However, oral provocation tests performed after 
proper elimination diets are frequently needed to confirm the diagnosis, especially in multiple 
food allergies and chronic diseases, such as atopic dermatitis and asthma, or when non-IgE-
mediated mechanisms are suspected. Oral challenges can be performed openly, single-blindly 
or double-blindly. The double-blind, placebo-controlled food challenge is considered the 
"gold standard" for diagnosis of food allergy, because this method minimizes subjective bias 
of the patient and supervising physician (Sicherer 1999). The atopy patch test, an 
epicutaneous test with foods, is a promising tool that may be helpful in the diagnosis of 
delayed food-allergic reactions. However, further studies are needed before this test can be 
recommended for routine clinical use (Niggemann 2002). 
 
The only management of food allergy is strict dietary avoidance of the offending foods. About 
85% of children outgrow their reactivity to many foods, such as milk, egg, and wheat by the 
age of 3 to 5 years (Dannaeus and Inganas 1981, Sampson and Scanlon 1989). In contrast 
allergy to peanut, tree nuts, and seafood, as well as food allergies in adults, tend to persist 
(Skolnick et al. 2001). 
 
5.6 Anaphylaxis 
The term anaphylaxis was introduced over 100 years ago by Portier and Richet, who were the 
first to report the experimental induction of fatal hypersensitivity. The term derived from the 
Greek words "ana" meaning against and "phylaxis" meaning protection (Portier and Richet 
1902). Today anaphylaxis is defined as "a severe, life-threatening, generalized, or systemic 
hypersensitivity reaction" (Johansson et al. 2001). It results from the rapid release of potent 
mediators from tissue mast cells and peripheral blood basophils, and is most often IgE-
mediated (Nicklas et al. 1998). Many authors use the term anaphylactoid reaction for 
clinically indistinguishable reactions caused by other immunologic or non-immunologic 
mechanisms. Preferably, the terms non-IgE-mediated allergic anaphylaxis and nonallergic 
anaphylaxis, respectively, are recommended for these kind of reactions (Johansson et al. 
2001).  
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5.6.1 Clinical features 
Systemic anaphylaxis represents the most severe manifestation of type I allergy, yet no 
universally accepted clinical definition exists. The target organs include the skin, the 
gastrointestinal tract, and the respiratory and cardiovascular systems; the combination of signs 
and symptoms shows considerable variation. The three main indicators of anaphylaxis are 
generalized urticaria / angioedema, bronchospasm, and hypotension. Often anaphylaxis is 
defined as a reaction, where at least two of these main indicators are present (Pumphrey and 
Stanworth 1996).  Clinical features of systemic anaphylaxis are complied in Table 2. 
 
Table 2. Clinical features of systemic anaphylaxis (modified from Lane and Lee 1997) 
Skin manifestations Warmth and pruritus of extremities and groin 
 
Generalized erythema 
 Generalized urticaria 
 Angioedema 
 
 
Gastrointestinal manifestations Nausea, vomiting 
 Abdominal pain 
 Diarrhea 
  
Respiratory manifestations Upper airway obstruction (laryngeal edema) 
 Lower airway obstruction (wheezing, asthma) 
 Cyanosis and asphyxia 
 Respiratory arrest 
  
Cardiovascular manifestations Tachycardia 
 
Hypotension, circulatory shock 
 Depressed myocardial function, arrythmias 
 Cardiac arrest 
 
5.6.2 Etiological agents 
Virtually any substance can provoke an anaphylactic reaction. The pattern of etiological 
agents triggering anaphylaxis has changed over the decades reflecting changes in the 
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environment and the use of new drugs and materials. In the 1930s, when hyperimmune horse 
serum was used as a source of antitoxins against tetanus and difteria and as antisera against 
bacterial infections, it accounted for 50% of fatalities caused by anaphylaxis. In the 1970s 
penicillin was responsible for about 75% of all cases of anaphylaxis (Lane and Lee 1997). In 
the 1980s the first cases of EIA and FDEIA were described (Sheffer and Austen 1980, Kidd et 
al. 1983). The AIDS crisis led to a dramatic increase in the use of latex products in the 1980s 
and 1990s, and latex was recognized as an occupational hazard for healthcare workers and 
patients during medical procedures. The incidence of food anaphylaxis has increased during 
the last decade (Lane and Lee 1997). In addition, cases of FDEIA have been described with 
increasing frequency (Romano et al. 2001). Currently, food is the single most common cause 
of anaphylaxis in the Western countries, accounting for about 35 to 50% of cases treated at 
emergency departments. It is followed by drugs in 9 to 35% and insect venoms in 2 to 16% of 
cases (Pumphrey and Stanworth 1996, Novembre et al. 1998, Yocum et al. 1999, Pastorello et 
al. 2001). 
 
5.6.3 Food anaphylaxis 
No epidemiological data on the overall prevalence of food anaphylaxis exist, but the 
prevalence of severe food allergy seems to be increasing. The spectrum of foods triggering 
anaphylaxis is broad and reflects the pattern of food sensitization in different countries. In the 
USA and UK, where peanuts are consumed extensively, peanut allergy is the most common 
cause of food-induced anaphylaxis (Pumphrey and Stanworth 1996). On the contrary, peanut 
allergy is relatively rare in Scandinavia, most probably owing to the much lower rate of 
consumption. Anaphylaxis to fish, shrimps, and crabs is more common in countries, where 
seafood is a central dietary component (Novembre et al. 1998). Nevertheless, peanut, tree 
nuts, fish, shellfish, egg, milk, and soy account for the vast majority of food-induced 
anaphylactic reactions worldwide (Wutrich and Ballmer-Weber 2001).  
 
The first series of fatal reactions to foods, comprising seven cases of fatal anaphylaxis in 
highly atopic adults after unknowing ingestion of the allergenic food, was not published until 
1988 (Yunginger et al. 1988). In the 1990s, fatalities due to food anaphylaxis were reported 
increasingly. In these studies the most common cause was peanut followed by tree nuts; other 
foods included milk, egg, fish, and crab (Sampson et al. 1992, Hide 1993, Foucard and 
Malmheden Yman 1999, Pumphrey 2000, Bock et al. 2001). A Swedish study described four 
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deaths caused by soy anaphylaxis in patients with severe peanut allergy without previously 
known allergy to soy (Malmheden Yman 1999). The majority of the victims of fatal food 
anaphylaxis have been adolescents or young adults with bronchial asthma and a prior history 
of allergy to the food that caused the fatal reaction. In most cases, the use of adrenaline 
(epinephrine) was delayed or inappropriate, and the patients did not have an emergency 
medication kit (adrenaline autoinjector, oral corticosteroids and antihistamines) available at 
the time of the reaction (Sampson et al. 1992, Foucard and Malmheden Yman 1999, Bock et 
al. 2001). Asthma seems to be strongly associated with fatalities due to food anaphylaxis. In 
the UK fatal anaphylactic reactions have been registered since 1992. Between 1992 and 1998, 
37 of the 164 registered fatalities were caused by food. All 37 victims experienced respiratory 
difficulty, and 86% progressed to respiratory arrest. In the remaining 14%, a combination of 
shock and respiratory arrest was assumed (Pumphrey 2000). 
 
5.6.4 Exercise-induced anaphylaxis 
Classic EIA is a unique form of physical allergy, where exercise triggers anaphylactic 
reactions without exogenous allergen exposure. The clinical manifestations are 
indistinguishable from those of IgE-mediated anaphylaxis (Sheffer and Austen 1980, Sheffer 
et al. 1983). Symptoms progress into vascular collapse in about 30% and into laryngeal 
edema in almost 70% of patients. Exercise should be discontinued at the earliest symptom, 
usually pruritus and cutaneous warmth, and the patients should never exercise unaccompanied 
(Nicklas et al. 1998). The syndrome is distinct from other physical allergies, i.e., cholinergic 
urticaria and exercise-induced asthma. In the latter, bronchospasm is the primary symptom, 
while skin manifestations as well as vascular collapse are usually absent. Cholinergic urticaria 
is characterized by small, punctate urticarial wheals that develop in response to a rise in core 
body temperature, including exercise, fever, emotional stress, or a hot shower. Vascular 
collapse or other systemic signs or symptoms are rare (Volchek and Li 1997). 
 
The episodes are not consistently reproducible, given that the exercise activity as well as the 
degree of exertion provoking EIA varies greatly. The most common activities include aerobic 
sports, such as jogging, brisk walking, dancing, and ball games, but almost any type of 
exertion can provoke symptoms (Shadick et al. 1999). The exact mechanism is still 
incompletely understood. Skin biopsies have revealed mast cell degranulation (Sheffer et al. 
1985), and symptomatic attacks are associated with elevated plasma histamine, tryptase, and 
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leukotriene levels (Lewis et al. 1981, Schwartz 1995). However, the type of mast cells that 
participate in EIA has not been defined. In a 10-year follow-up survey, the frequency of 
attacks in most individuals tended to stabilize or decrease over time (Shadick et al. 1999). 
This appeared to result from individual modification of exercise and avoidance of known 
precipitants. In the same study, 71% had at least one atopic disorder or a family history of 
atopy, and the patients were mostly adolescents or young adults. One fatal case of EIA has 
been documented, but it is possible that there are other fatalities, where EIA has not been 
recognized as the cause of death (Ausdenmoore 1991). Several case reports on familial EIA 
exist (Grant et al. 1985, Longley and Panush 1987). EIA is often related to intake of specific 
foods before exercise, or certain medications, such as nonstreroidal anti-inflammatory drugs 
(van Wijk et al. 1995). In the 10-year follow-up survey, 37% of the 276 cases of EIA were 
considered food-dependent (Shadick et al. 1999). 
 
5.6.5 Food-dependent, exercise-induced anaphylaxis 
FDEIA is regarded as a subset of classic EIA. In this severe form of food allergy, ingestion of 
a specific food prior to physical exercise triggers symptoms of anaphylaxis. In cases of 
unspecific FDEIA, ingestion of any food before exercise may elicit symptoms (Kidd et al. 
1983). Patients experience recurrent episodes of generalized urticaria or anaphylaxis during 
exercise, however the amount of food ingested as well as the degree of exercise needed to 
provoke symptoms varies greatly. This makes the attacks unpredictable and difficult to 
diagnose. Exercise or food ingestion alone fails to elicit symptoms, although patients with 
specific FDEIA usually exhibit IgE antibodies to the offending food (Kidd et al. 1983).  
 
The first case of FDEIA was described in 1979 (Maulitz et al.), and since then numerous 
other case reports have been published. The following foods have been associated with EIA: 
seafood (squid, octopus, crab, oyster and shrimp) (Maulitz et al. 1979, Dohi et al. 1991); 
cereal products (wheat, rye, barley, and corn) (Kushimoto and Aoki 1985, Armentia et al. 
1990, Guinnepain et al. 1996, Varjonen et al. 1997, Pauls and Cross 1998); nuts (hazelnut, 
and walnut) (Guinnepain et al. 1996); legumes (peanut, beans and soybean) (Romano et al. 
1995, Guinnepain et al. 1996), fruits (peach, grape, apple, pear, orange, kiwi, plum, and 
banana) (Buchbinder et al. 1983, Romano et al. 1995, Dohi et al. 1991, Anibarro et al. 1994, 
Guinnepain et al. 1996, Kivity et al. 1988); vegetables (celery, tomato, lettuce, fennel and 
potato) (Kidd et al. 1983, Caffarelli et al. 1996, Romano et al. 1995); dairy products (milk, 
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cheese, and egg) (Guinnepain et al. 1996, Shadick et al. 1999, Asero et al. 1997); chicken 
(Laufer 1987), poppy seed (Kutting and Brehler 2000), snail (Longo et al. 2000), matsutake 
mushrooms (Okano and Sakuma 1997), and alcohol (Shadick et al. 1999). Although usually 
provoked by a single food, some cases of FDEIA may require intake of multiple foods 
(Aihara et al. 2001). Despite the wide range and increasing number of associated foods, the 
most frequently reported trigger of FDEIA is wheat (Kushimoto and Aoki 1985, Armentia et 
al. 1990, Dohi et al. 1991, Guinnepain et al. 1996, Varjonen et al. 1997). 
 
The pathophysiologic mechanisms underlying specific FDEIA are unknown. The reactions 
seem to be IgE-mediated, but the role of exercise remains obscure. Abnormal responses of the 
autonomic nervous system (Fukutomi et al. 1992) as well as basal eosinophil hyperactivity 
(Romano et al. 1997) have been demonstrated in some patients with FDEIA. It has been 
hypothesized that reduced blood flow to the gut during exercise may increase gut permeability 
and allergen absorption, allowing ingested allergens to rapidly enter the circulation. Another 
explanation is that exercise could lower the threshold of mast cell degranulation to another 
stimulus, such as IgE binding (Kivity et al. 1988). The effects of exercise on mast cell 
degranulation could further be potentiated by gastrin, which is released in response to 
exercise, and has been shown to induce histamine release from human cutaneous mast cells 
(Tharp et al. 1984) and from rat and human gastric mucosa (Man et al. 1981, Main and Pearce 
1982). Furthermore, it has been speculated that exercise could induce changes in 
gastrointestinal mucosal enzyme activities, leading to facilitated allergen absorption or 
generation of new epitopes by enzymatic modification of ingested peptides. A study on 
patients with WDEIA showed enhanced SPT reactions to wheat proteins after pepsin 
digestion, but decreased reactions after trypsin digestion (Kushimoto and Aoki 1985). 
 
5.7 Cereals 
Cereal products are the most important source of food and a major source of dietary protein 
worldwide, accounting for more than half of the world's daily energy consumption. Wheat 
(Triticum aestivum) is the most widely cultivated cereal. It belongs to the Triticeae tribe of the 
grass family (Gramineae) together with rye (Secale cereale) and barley (Hordeum vulgare). 
Oats (Avena sativa) and rice (Oryza sativa) belong to separate tribes in the grass family. The 
major temperate cereals - wheat, rye, barley, and oats - are cultivated in Finland, whereas 
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corn, sorghum, and millets, classified to the grass subfamily Panicoideae, are the major 
tropical cereals (Bietz 1982, Shewry and Tatham 1990). 
 
5.7.1 Seed structure  
Cereals produce one-seeded dry fruits, known as seeds or kernels, which consist of three 
distinct parts: the endosperm, bran, and germ that are separated during the milling process to 
produce flour (Figure 1). The endosperm of the wheat kernel comprises about 83% of the total 
kernel mass. It contains the greatest proportion of protein, carbohydrates in starch granules, 
and iron, as well as some B-vitamins and soluble fibers. The bran, accounting for about 14% 
of the weight, is the outer covering of the kernel that has a low protein content. It is rich in 
insoluble dietary fibers, trace minerals, and B-vitamins. The germ is the embryo or sprouting 
section of the seed comprising less than 3% of the kernel weight. It contains 10% lipids, 
minimal quantities of protein, and a large share of the kernel's B-vitamins and trace minerals. 
Whole-wheat flour contains all three parts of the kernel, whereas white flour is made from the 
endosperm only (Hosney 1986). 
 
Figure 1. A longitudinal section of the wheat kernel 
 
 
5.7.2 Cereal proteins 
The wheat kernel contains 10 to 15% protein, which is mostly present in the endosperm. 
Many proteins in the mature seed have either metabolic or structural roles, still the vast 
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majority of seed proteins are storage proteins that function as a nitrogen reserve for the 
germinating embryo (Shewry et al. 1995). Early studies on seed proteins (Osborne 1924) 
classified wheat proteins into four groups on the basis of their extraction and solubility in a 
series of solvents: water (albumins), dilute salt solutions (globulins), aqueous alcohol 
(gliadins), and dilute alkali or acid (glutenins) (Figure 2). This classification is still much in 
use, despite the fact that it poses several problems. The main concern is that many factors, 
such as the fineness of milling, the vigor of shaking, the type and concentration of alcohol 
used, and the extraction temperature, affect the extractability of proteins. Thus, any proteins 
not extracted as albumins or globulins are present in the gliadin fraction. As all four fractions 
are complex polymorphic mixtures, they are likely to be somewhat contaminated by proteins 
from other fractions (Shewry and Miflin 1985).  
 
Albumins and globulins 
The water-soluble albumins and salt-soluble globulins account for 14% of total wheat 
proteins. They are mainly structural proteins and metabolically active enzymes, such as α- and 
β-amylases, which function in hydrolyzing starch. Inhibitors of these enzymes (α-amylase 
inhibitors) comprise two thirds of the albumin fraction. The molecular masses of albumins 
and globulins are mainly under 40 kDa (Wrigley and Bietz 1988, Shewry et al. 1995). 
 
Figure 2. Proportions of wheat proteins classified according to solubility (Osborne 1924) 
 
Prolamins 
The water/salt-insoluble glutenins and gliadins are known as prolamins or gluten, a term 
originally introduced in 1745 for the visco-elastic mass remaining after removal of starch 
from the wheat dough (Beccari 1745). They are the major storage proteins of the wheat grain 
accounting for 86% of the total proteins. Gluten is responsible for the ability of wheat flour to 
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be baked into bread by creating an elastic dough capable of holding gas. The corresponding 
prolamins in other cereal grasses, i.e., secalins in rye, hordeins in barley, avenins in oats, and 
zeins in corn, do not share the unique baking properties of wheat gluten. The prolamin content 
of oats is considerably lower that that of wheat, rye, or barley (Shewry and Tatham 1990). 
 
The alcohol-soluble gliadins are monomeric proteins, whereas the alcohol insoluble glutenins 
are polymers of high- or low-molecular-weight subunits held together by covalent disulfide 
bonds (Shewry et al. 1995). The total number of gliadins is over 40, and they can be further 
categorized into α-, γ-, and ω-types on the basis of their electrophoretic mobility in a starch 
gel (Woychik et al. 1961). The molecular masses of α- and γ-gliadins overlap, ranging from 
30 to 44 kDa, and those of ω-gliadins range from 50 to 80 kDa (Miflin et al. 1983).  
 
The term prolamin reflects the fact that these proteins are unusually rich in proline and 
glutamine amino acids, present in highly repetitive sequence motifs. The abundance of 
hydrophobic amino acids contributes to the insolubility of prolamins into water and buffers 
(Shewry and Miflin 1985). The chemical structure and the chromosomal location of the 
structural genes of wheat, rye, and barley prolamins divide them into three homologous 
groups: the sulphur-rich, sulphur-poor, and high-molecular-weight (HMW) prolamins. The 
sulfur-rich prolamins account for about 80% of the total prolamins. This highly polymorphic 
group includes both monomeric and polymeric proteins: the α- and γ-type gliadins and low-
molecular-weight subunits of glutenin in wheat, γ-secalins in rye, and B hordeins in barley. 
The basic structure shared by all sulfur-rich prolamins consists of an N-terminal domain of 
repeated sequences and a nonrepetitive C-terminal domain. The sulfur-poor prolamins, 
comprising ω-gliadins in wheat, ω-secalins in rye, and C hordeins in barley, account for 10 to 
20% of the total prolamins. They are monomeric proteins that lack cysteine residues and thus 
disulfide bonds. The sulfur-poor prolamins consist almost entirely of repeats; glutamine, 
proline and phenylalanine account for about 80% of all amino acids. The HMW prolamins 
account for about 7 to 9% of wheat, and less than 5% of rye and barley prolamins. In wheat 
they are referred to as HMW subunits of glutenin, in barley as D hordeins, and in rye as 
HMW secalins. They are largely present as disulfide -linked aggregates with molecular masses 
ranging from 90 to 145 kDa. HMW prolamins are characterized by a relatively high glycine 
(over 12%) and low proline content (Miflin et al. 1983, Shewry and Miflin 1985, Shewry and 
Tatham 1990).  
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5.8 IgE-mediated wheat allergy and allergens 
Wheat allergy reflects well the diverse manifestations of food allergy. Defined as an adverse 
immunologic reaction to wheat (Johansson et al. 2001), it encompasses a broad spectrum of 
disorders with different pathomechanisms and clinical manifestations. Depending on the route 
of allergen exposure and the underlying immunologic mechanisms, wheat allergy may 
manifest as classic food allergy affecting the skin, gut, or respiratory tract, exercise-induced 
anaphylaxis, occupational asthma and rhinitis, contact urticaria, intestinal inflammation in 
celiac disease, or a blistering skin eruption in dermatitis herpetiformis (Johansson et al. 2001). 
With the exception of celiac disease and dermatitis herpetiformis, IgE antibodies play a 
central role in all of the above. 
 
Ingestion and inhalation are the two main routes of sensitization to wheat allergens. Wheat is 
a major dietary component in many countries. In Finland it is introduced to the infant's diet 
around the age of five months, but exposure to wheat allergens may occur already through 
breast-milk (Linna 1996). Furthermore, wheat flour allergens are inhaled and handled when 
milling, baking, and cooking.  
 
5.8.1 Baker's asthma  
Baker's asthma is an IgE-mediated occupational disease of millers and bakers caused by 
inhalation of cereal flour. It is usually accompanied by rhinitis and often by conjunctivitis and 
contact urticaria in the hands (Baur et al. 1998). However, most patients with baker's asthma 
are able to ingest wheat products without symptoms. Asthmatic symptoms in bakers were 
described more than 300 years ago. Since the first cases of occupational allergy to inhaled 
flour in 1929 (de Besche), numerous studies have been published on baker's asthma. At 
present it the most common form of occupational asthma in many countries. The vast 
majority of patients, about 60 to 70%, have IgE to wheat flour. Other known allergens include 
rye, barley, soybean, baking additives, and storage mites (Savolainen 1997, Baur and Posch 
1998). 
 
Several studies have demonstrated IgE binding to the gliadin and glutenin fractions of wheat 
(Walsh et al. 1985, Weiss et al. 1993, Sandiford et al. 1997, Maruyama et al. 1998). 
However, the water/salt-soluble albumins and globulins are the most relevant allergenic 
proteins for patients with baker's asthma, accounting for about 70 to 80% of the specific IgE-
  
 
31 
binding activity (Weiss et al. 1993). Allergens characterized at the molecular level belong to 
the family of α-amylase/trypsin inhibitors (Fränken et al. 1994). They are water-soluble 
proteins with molecular masses between 14 and 17 kDa, including subunits of the tetrameric 
α-amylase inhibitor (Sanchez-Monge et al. 1992, Armentia et al. 1993), dimeric α-amylase 
inhibitors (Fränken et al. 1994, Posch et al. 1995, Amano et al. 1998), the monomeric α-
amylase inhibitor (Walsh and Howden 1989, Armentia et al. 1993, Amano et al. 1998), and a 
homologue of the barley trypsin inhibitor (Amano et al. 1998). Other characterized wheat 
allergens include a 36 kDa wheat glycoprotein with peroxidase activity (Sanchez -Monge et al. 
1997), a 27 kDa protein similar to the acyl-CoA oxidase variants of rice and barley, and a 39 
kDa protein similar to fructose-bisphosphate-aldolase in corn and rice (Posch et al. 1995, 
Weiss et al. 1997). A recent study demonstrated by 2-dimensional immunoblotting a large 
degree of variation in sensitization to different wheat proteins in 10 individuals with baker's 
asthma. Each patient had an individual IgE-binding pattern with 4 to 50 different IgE-binding 
spots. The four most frequently recognized proteins were identified by mass spectrometric 
fingerprinting. Two of them showed similarity to isoforms of glycerinaldehyde-3-phosphate 
dehydrogenases from barley, one was similar to triosephosphate isomerase from barley, and 
one was identified as serpin, a serine protease inhibitor from wheat (Sander et al. 2001). 
 
5.8.2 Allergy to ingested wheat in childhood 
The first case of IgE-mediated allergy to ingested wheat was published in 1969. A highly 
atopic boy with severe gastrointestinal and respiratory symptoms after wheat ingestion 
showed high titers of IgE to α-gliadin (Goldstein 1969). Later, Hoffman (1975) demonstrated 
IgE reactivity by RAST against wheat albumins and globulins in 11 atopic children presenting 
with asthma, urticaria, or eczema upon wheat ingestion or inhalation. Three additional 
children with severe atopic eczema and probable ingested wheat allergy had high IgE levels 
against gluten (Hoffman 1975). On the contrary, Sutton et al. (1982) showed higher RAST 
values to globulins and glutenins than to gliadins or albumins in 20 children with symptoms 
of asthma or eczema after wheat ingestion. Räsänen et al. (1994) studied 18 atopic children 
with immediate or delayed symptoms on oral wheat challenge, and demonstrated by RAST 
and basophil histamine release that half of these children had IgE specific to the gliadin 
fraction. An immunoblotting study by Varjonen et al. (1995) showed IgE binding to 26, 38, 
and 69 kDa proteins in the albumin/globulin fraction of wheat in over 50% of 34 sera from 
wheat-allergic children with atopic dermatitis. The same study showed a clear correlation 
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between positive skin prick test responses to gliadin and positive oral wheat challenge results 
(Varjonen 1995). Jones et al. (1995) demonstrated IgE cross-reactivity between the water/salt-
soluble proteins of cereal grains and grasses, yet clinical reactivity to more than one cereal 
was observed in only 20% of the cases. IgE antibodies from patients with wheat allergy, but 
not from patients with grass pollen allergy, bound to 20 and 47 kDa wheat proteins in 
immunoblotting (Jones et al. 1995). James et al. (1997) identified by immunoblotting wheat 
α-amylase inhibitor as a relevant allergen in five children with ingested wheat allergy, 
suggesting that it represents a sensitizing allergen both after ingestion and inhalation. 
 
5.8.3 Allergy to ingested wheat in adults 
Ingestion of wheat products may in some adults lead to exacerbation of atopic dermatitis, but 
the clinical significance of IgE-mediated wheat allergy in such adults remains obscure. Only a 
few studies examining the role of wheat-specific IgE in adults with atopic dermatitis have 
been carried out. Yokota et al. (1992) identified by immunoblotting six IgE-binding wheat 
proteins with molecular masses between 33 and 98 kDa using sera of 15 adults with severe 
atopic dermatitis and positive RAST scores to wheat. In another study, Varjonen et al. (1994) 
examined 35 patients with severe atopic dermatitis and positive RAST and / or SPT responses 
to wheat. IgE immunoblots with the patient sera showed a total of 36 different IgE-binding 
protein bands with molecular masses ranging from 7 to 84 kDa. The most frequently observed 
band was a 26 kDa protein recognized by 43% of the sera. 
 
5.8.4 Wheat-dependent, exercise-induced anaphylaxis 
Though an increasing number of food products have been linked with EIA, the most 
frequently reported food is wheat. The first six cases of WDEIA were published in 1985. 
These patients had negative wheat RAST scores to the water-soluble fraction, but positive 
SPT responses to wheat gliadin, glutenin, and pepsin-digested gluten (Kushimoto and Aoki 
1985). Thereafter cases of WDEIA have been reported in Spain (1 patient) (Armentia et al. 
1990), Japan (6 patients) (Dohi et al. 1991, Katsunama et al. 1992, Juji et al. 1994, Fujimoto 
et al. 1995), Italy (2 patients) (Romano et al. 1995) and France (10 patients) (Guinnepain et 
al. 1996). Varjonen et al. (1997) reported five patients from Finland with WDEIA, who 
showed extensive serum IgE binding in immunoblotting to the ethanol-soluble gliadin 
fraction of wheat and corresponding fractions in rye, barley, and oats. SPT responses were 
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positive to both the water/salt-soluble and gliadin fractions of wheat. Treatment of these 
patients with a gluten-free diet led to symptom resolution. 
 
5.9 Celiac disease and tissue transglutaminase 
Celiac disease or gluten-sensitive enteropathy is a multifactorial disorder caused by an 
inappropriate T-cell-mediated immune response to ingested gluten (i.e., gliadins and 
glutenins) and related proteins in rye and barley. The disease is characterized by chronic 
inflammation of the small intestine resulting in villous atrophy and flattening of the mucosa. 
Clinical symptoms, including abdominal symptoms, weight loss, diarrhea, and malabsorption, 
may however be absent. Genetic factors are strongly associated with susceptibility to celiac 
diseas; the majority of patients express the human leukocyte antigen DQ2 or DQ8 (Sollid 
2000). Patients with untreated celiac disease have IgG and IgA antibodies to various antigens, 
including gluten and the autoantigen tissue transglutaminase (tTG) (Dieterich et al. 1997). 
The production of these antibodies is controlled by exposure to dietary gluten, and its strict 
dietary avoidance leads to complete remission.  
 
Gliadin-specific CD4+ T cells can be isolated from the intestinal mucosa of celiac patients. 
These T cells recognize gliadin peptides presented in the context of DQ2 or DQ8 molecules 
and have a cytokine profile dominated by IFN-γ, a major Th1-type cytokine (Sollid 2000, 
2002). More than 10 antigenic epitopes have been identified in gliadin and glutenin proteins. 
Most of these T-cell epitopes are preferably recognized in a deamidated form, i.e., specific 
glutamine residues have been converted into glutamic acid by the enzyme tTG (Molberg et al. 
1998, Anderson et al. 2000). 
 
tTG is a member of the transglutaminase enzyme family. It is a ubiquitous multifunctional 
enzyme that catalyzes calcium-dependent cross-linking or deamidation of specific glutamine 
residues. Deamidation is the conversion of glutamine into glutamic acid, whereas cross-
linking involves an acyl transfer reaction between the carboxamide group of a peptide-bound 
glutamine and the primary amine group of a lysine, resulting in the formation of an 
irreversible protein cross-link. This covalent isopeptide bond is highly resistant to proteolysis 
and denaturants (Chen and Mehta 1999). Unlike other transglutaminases, tTG can also 
hydrolyze ATP and GTP and act as a signal transducing G-protein (Im et al. 1997). Although 
tTG has been implicated in diverse biological processes, including cell growth and 
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differentiation, tissue repair, receptor-mediated endocytosis, and the induction of apoptosis, 
its precise physiological function remains unknown (Chen and Mehta 1999). 
 
5.9.1 Role of tTG in celiac disease 
In the small intestine, tTG is located beneath the basal membrane in the subepithelial region 
(Mollberg et al. 1998). Relatively few proteins can serve as substrates for tTG, however 
gliadins, having a glutamine content of 30 to 50%, are known to be optimal substrates for this 
enzyme (Larre et al. 1993). tTG has a central role in the pathogenesis of celiac disease. 
Besides being the target of disease-specific autoantibodies, it generates potent T-cell epitopes 
by deamidation of specific glutamine residues on gliadin peptides. Deamidation introduces a 
negative charge on the peptide, which enhances its binding affinity to the disease-associated 
DQ2 molecule (Molberg et al. 1998, Andersson et al. 2000). 
 
In addition to gliadin deamidation, tTG can form gliadin-gliadin complexes and incorporate 
itself into high-molecular-weight complexes with gliadins (Dieterich et al. 1997, Molberg et 
al. 1998). It has been speculated that tTG-specific B cells could bind and process tTG-gliadin-
peptide complexes and present them to gliadin-specific T cells. Activation of these T cells 
would, in turn, provide help for B cells in anti-tTG IgA production. This could explain the 
dependency of autoantibody production on dietary exposure to gliadin (Sollid 2002). 
 
5.9.2 Activation of  tTG 
Under physiological conditions tTG exists in an inactive intracellular form (Smethurst and 
Griffin 1996). Elevated calcium levels induce a conformational change that releases tTG and 
activates its cross-linking function (Di Venere et al. 2000, Liu et al. 2002). Increased activity 
has been observed under stress-like conditions, including inflammation, infection, metabolic 
and oxidative stress (Kim et al. 2002). In addition, many molecules, such as the cytokines IL-
6 (Suto et al. 1993) and TNF-α (Kuncio et al. 1998), retinoids (Davies et al. 1985), 
glucocorticoid hormones (Johnson et al. 1998), and reactive oxygen species (Mirza et al. 
1997), can induce tTG expression and increase its activity. Besides celiac disease, 
inappropriate tTG activation is related to various other disease processes, including 
neurogenerative diseases, tissue fibrosis, atherosclerosis, and cataract formation (Kim et al. 
2002).  
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6. AIMS OF THE STUDY 
 
The aims of this study were to identify and purify clinically significant wheat allergens and to 
study allergen-specific humoral, cellular, and SPT responses in patients with WDEIA and in 
children with challenge-confirmed wheat allergy. 
 
The specific aims were: 
 
1. To identify and characterize clinically important wheat allergens involved in WDEIA. 
2. To evaluate the clinical significance of these allergens in children with challenge-
confirmed allergy to ingested wheat. 
3. To characterize cross-reactive allergens in rye, barley, and oats and to evaluate their 
significance in WDEIA. 
4.  To study allergen-specific, cellular responses in WDEIA. 
5. To study the effects of pepsin and trypsin digestion and subsequent tTG treatment on the 
IgE-binding properties and in vivo reactivity of purified ω-5 gliadin in WDEIA. 
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7. MATERIALS AND METHODS 
7.1 Study subjects 
7.1.1 Patients with WDEIA (I, II, IV, V) 
The study comprised a total of 32 patients (13 females, 19 males) with WDEIA. Their mean 
age at onset of symptoms was 34 years (range 18 to 66 years) and at diagnosis 40 years (range 
24 to 77 years). All patients had experienced recurrent episodes of generalized urticaria or 
anaphylaxis when exercising after ingestion of wheat products and had positive SPT 
responses to wheat (1:10 w/v in 0.9% NaCl) and crude gliadin (1 mg/ml, Sigma, St. Louis, 
MO, USA) extracts.  
 
7.1.2 Children with wheat allergy (III) 
Sera were obtained from 40 children (mean age 2.5, range 0.7-8.2 years) with suspected 
wheat allergy, presenting with atopic dermatitis, gastrointestinal, and / or respiratory 
symptoms. Wheat allergy was diagnosed with open or double-blind, placebo-controlled oral 
wheat challenge. Of these 40 children, 23 had a positive SPT to wheat (1:10 w/v 0.9% NaCl) 
and 25 a positive wheat CAP RAST (>0.35 KU/L; CAP RAST, Pharmacia, Uppsala, 
Sweden). All but one of the children presented with moderate to severe atopic dermatitis, 29% 
suffered from gastrointestinal, and 12% from respiratory food allergy symptoms. Twenty-nine 
percent had a history of asthma, and 15% had allergic rhinitis. Other foods suspected of 
causing allergy were cow's milk in 26 (65%), egg in 16 (40%), and cereals other than wheat in 
23 (58%) children. 
 
7.1.3 Control subjects (I-V) 
The control sera in studies I and II were from 31 adult patients with wheat allergy having 
positive SPT and RAST responses to wheat and from 23 adults without wheat allergy with 
negative SPT and RAST responses to wheat. Of the wheat-allergic patients, 16 (mean age 31, 
range 20 to 53 years) had baker’s asthma or allergic occupational rhinitis from inhalation of 
wheat flour, and 15 (mean age 29, range 18 to 50 years) experienced mucosal, skin, or 
gastrointestinal symptoms on inhalation or ingestion wheat. The group without wheat allergy 
comprised 12 adults (mean age 37, range 18 to 82 years) with recurrent urticaria and 11 
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patients (mean age 48, range 29 to 71 years) with celiac disease. In study IV, venous blood 
samples (peripheral blood mononuclear cells and / or sera) were obtained from 21 adults 
(mean age 38, range 18 to 56 years) with no symptoms of wheat allergy or exercise-induced 
anaphylaxis and negative SPTs to wheat and gliadin.  In study III, the control sera were 
collected from 22 children (mean age 10.6, range 6.3 to14.9 years) with no evidence of food 
allergy and negative SPTs to wheat, rye, barley, and oats. The control group for the skin prick 
tests in Study V consisted of one adult (47 years) with exercise-induced anaphylaxis not 
related to food ingestion and three patients with immediate ingested wheat allergy not related 
to exercise: one child (9 years) and two adults (19 and 23 years) with wheat allergy persisting 
from childhood. 
 
7.2 Extraction and purification of cereal proteins 
To extract proteins in a wide solubility range, cereal proteins were extracted with 50% 
acetonitrile (ACN) - 0.1% trifluoroacetic acid (TFA), phosphate-buffered saline (PBS), or 
75% ethanol. ACN is polar organic solvent that extracts both water/salt-soluble and insoluble 
proteins, and TFA is an acid used as an additive in high performance liquid chromatography 
(HPLC) (Neville 1996). The ACN-TFA extract was further divided into two solubility 
fractions, i.e., the proteins soluble in water or dilute acid, and those soluble in ACN only. 
Stepwise extraction with PBS and ethanol was used to extract the water/salt-soluble and 
insoluble proteins, respectively. All extracts were stored at -20°C. It must, however, be noted 
that all fractions separated by solubility are likely to contain small amounts of protein from 
other solubility fractions as well (Shewry and Miflin 1985). The characteristics of the various 
wheat extracts are summarized in Table 1.  
 
Table 1. Major protein fractions and solubility of the different wheat extracts 
 
Solvent Major protein fractions Solubility 
ACN (50%) Gliadins, glutenins Water/salt-insoluble 
Water/TFA (0.1%) Albumins, globulins  
(gliadins, glutenins) 
Water/salt-soluble  
(Water/salt-insoluble) 
PBS Albumins, globulins Water/salt-soluble 
Ethanol (75%) Gliadins Water/salt-insoluble 
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7.2.1 Purification of wheat proteins extracted with ACN (I-V) 
The purification procedure is illustrated in Figure 1 (page 49). Wheat grains (10 g, Triticum 
aestivum; cultivar, Tjalve) were ground and extracted with 100 ml of 50% ACN - 0.1% TFA 
overnight at room temperature with continuous shaking. After centrifuging for 20 minutes at 
30 000g the supernatant was collected, filtered through a 0.22 µm filter (GV Durapore 
Steritop, Millipore Bedford, MA, USA), and concentrated to one third in a vacuum centrifuge, 
which resulted in precipitation of the ACN-soluble proteins. After centrifuging at 10 000g for 
15 minutes the supernatant (water-TFA extract) was collected, and the precipitate (ACN 
extract) was dissolved in 6 ml of 10% ACN - 0.1% TFA.  
 
The ACN extract was purified by reversed-phase HPLC on a Resource RPC 3 ml column 
(Amersham Pharmacia Biotech, Uppsala, Sweden) using a linear gradient of ACN (10 to 60% 
in 60 minutes) in 0.1% TFA and a flow rate of 1 ml/min. Monitoring was done at 214 and 280 
nm, and 0.5 ml fractions were collected. The water/TFA extract was slightly acidic due to the 
presence of remnants of TFA. It contained mainly water-soluble, but most probably some 
acid-soluble wheat proteins as well. Proteins in the water/TFA extract were purified by gel 
filtration HPLC on a Superdex 75 HighLoad 16/60 column (Amersham Pharmacia Biotech) at 
a flow rate of 0.5 ml/min. Monitoring was done at 214 and 280 nm, and 0.5 ml fractions were 
collected. The fractions showing intense protein bands in sodium dodecyl sulphate- 
polyacrylamide gel electrophoresis (SDS-PAGE, see below) and Coomassie-blue staining 
were further purified by reversed-phase HPLC on a ProRPC HR 5/10 column  (Amersham 
Pharmacia Biotech) using a linear gradient of ACN (10 to 50% in 60 minutes) in 0.1% TFA 
and a flow rate of 1 ml/min.  
 
7.2.2 Purification of cereal proteins extracted with PBS and ethanol (II) 
Wheat (Triticum aestivum; cultivar, Tjalve), rye (Secale cereale; cultivar, Akusti), barley 
(Hordeum vulgare; cultivar, Arve) and oats (Avena sativa; cultivar, Veli) whole grains (5 g) 
were ground and extracted with 20 ml PBS, pH 7.0 for 2 hours at room temperature and 
overnight at +4°C with continuous shaking. After centrifuging for 20 minutes at 30 000g, the 
supernatants containing the water/salt-soluble proteins were collected and filtered through 
0.22 µm filters (GV Durapore Steritop, Millipore). The precipitates formed during 
centrifugation were extracted with 75% ethanol at room temperature overnight and 
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centrifuged for 20 minutes at 30 000g. The supernatants containing the ethanol-soluble 
proteins were collected and filtered through 0.22 µm filters (Millipore). 
 
The ethanol-soluble extracts were evaporated in a vacuum centrifuge and dissolved in 20% 
ACN containing 0.1% TFA. Gel filtration HPLC was performed on a Superdex 75 HR 10/30 
column (Amersham Pharmacia Biotech) at a flow rate of 0.5 ml/min in 20% ACN - 0.1% 
TFA. For the water/salt-soluble extracts, gel filtration was performed in PBS, pH 7.0. 
Monitoring was done at 214 and 280 nm, and 0.5 ml fractions were collected. The fractions 
showing positive bands in immunoblotting (see below) were further purified by reversed-
phase HPLC on a Resource RPC 3 ml column (Amersham Pharmacia Biotech) at a flow rate 
of 1 ml/min using a linear gradient of ACN (20 to 60% in 60 min) in 0.1% TFA. 
 
7.3 Protein separation by SDS-PAGE, staining, and quantification (I-V) 
Cereal proteins in the HPLC fractions were separated according to molecular weight by SDS-
PAGE and visualized by Coomassie-blue staining (Phast gel Blue R, Amersham Pharmacia 
Biotech). Approximately 1 to 3 µg of protein was evaporated in a vacuum centrifuge, and 15 
µl of electrophoresis sample buffer, containing 2% SDS, 5% 2β-mercaptoethanol, and 10% 
glycerol, was added. The samples were heated at +96˚C for 2 minutes and loaded on 12.6% 
SDS-polyacrylamide gels. Electrophoresis was performed at 200 V for 45 minutes on a Mini 
Protean II device (Bio-Rad, Hercules, CA, USA), then the gels were stained with Coomassie 
brilliant blue. The method of Lowry (Detergent-Compatible Protein Assay, Bio-Rad) was 
used for determination of protein concentration in all studies (Lowry et al. 1951). 
 
7.4 Amino-terminal sequencing (I, II) 
For amino-terminal sequencing, proteins were transferred to a ProBlott (Applied Biosystems, 
Perkin Elmer, Foster City, CA, USA) polyvinylidene difluoride (PVDF) membrane. 
Aminoterminal sequencing was performed with an Applied Biosystems 494 A ProciseTM 
sequencer (Applied Biosystems, Perkin Elmer). The allergen sequences were compared with 
known sequences in protein sequence databanks (Protein Information Resource-International 
Protein Sequence Database, SWISS-PROT Protein Sequence Database). 
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7.5 Production of anti-ω-5-gliadin antibodies in rabbit 
Purified ω-5 gliadin (75, 50, and 50 µg in 20% ethanol-PBS) was injected subcutaneously at 2 
weeks intervals into the dorsum of the metatarsal area of the rear leg of three young adult 
New Zealand White rabbits. The first injection contained 0.2 ml of Freund’s complete 
adjuvant, and the later injections were given without the adjuvant. Serum, containing high 
concentrations of IgG antibodies specific to ω-5 gliadin, was collected 2 weeks after the third 
injection. Serum from the rabbit showing the highest titer of anti-ω-5-gliadin antibodies was 
chosen for recognition of structures cross-reacting with ω-5 gliadin (data not shown). The 
immunization protocol was approved by the Institutional Animal Care and Use Committee of 
the National Public Health Institute. 
 
7.6 Digestion of purified ω-5 gliadin and treatment with tTG (V) 
ω-5 gliadin, a 65 kDa protein purified by reversed-phase HPLC from the ACN-extract of 
wheat, was evaporated in a vacuum centrifuge and dissolved in 0.1 M HCl, pH 1.8 containing 
5% DMSO. Pepsin (P6687, Sigma) was added at an enzyme-protein ratio of 1:100, and the 
mixture was incubated for 2 hours at +37˚C. Before trypsin digestion or tTG treatment, the 
samples were evaporated and washed twice with deionized water. Trypsin (T7418, Sigma) 
was added at an enzyme-protein ratio of 1:100 in 0.1 M Tris-HCl, pH 8, and the mixture was 
incubated for 4 hours at +37˚C. The reaction was stopped by heating at +96˚C for 10 minutes. 
The pepsin and pepsin-trypsin digests of ω-5 gliadin were treated with increasing amounts 
(enzyme-protein ratio 1:3, 1:1, 3:1) of tTG (guinea pig liver transglutaminase, T5398, Sigma) 
for 2 hours at +37˚C in 0.1 M Tris-HCl, pH 8, containing 2 mM CaCl2 . 
 
7.7 Fractionation of pepsin-digested ω-5 gliadin with gel filtration HPLC (V) 
The pepsin digest of ω-5 gliadin was fractionated by gel filtration HPLC on a Superdex 75 
HR 10/30 column (Amersham Pharmacia Biotech) at a flow rate of 0.4 ml/min in 20% ACN 
containing 0.1% TFA. Monitoring was done at 214 nm, and 0.4 ml fractions were collected, 
pooled and examined by immunoblotting (see below) before and after tTG treatment. The gel 
filtration fraction of the pepsin digest, corresponding to the highest peak of the chromatogram, 
formed the greatest amount of high-molecular-weight complexes after tTG treatment in 
immunoblotting. Before and after tTG treatment (30 µg, enzyme-protein ratio 3:1), 10 µg of 
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this fraction was subjected to HPLC gel filtration on a Superdex 200 HR10/30 column 
(Amersham Pharmacia Biotech). In addition, 30 µg of tTG was fractionated on the same 
column. Tris-buffered saline (TBS), pH 7.4 was used at a flow rate of 0.4 ml/min. Monitoring 
was done at 214 nm, and 0.4 ml fractions were collected. 
 
7.8 Immunochemical in vitro assays 
7.8.1 Immunoblotting (I, II, V) and immunoblot inhibition (II) 
Proteins or peptides separated by SDS-PAGE (Mini Protean II, Bio-Rad) were transferred 
from polyacrylamide gels to PVDF membranes (Immobilon-P, Millipore) by electroblotting 
on a Mini Trans-blot cell (Bio-Rad) for 1 hour at 40 V and 1 hour at 100 V. The membranes 
were blocked with 5% non-fat milk powder (Valio, Helsinki, Finland) in TBS, pH 7.4 (milk-
TBS) and incubated overnight at +4˚C with human serum diluted 1:10 or rabbit antiserum 
diluted 1:50 000 in 5% milk-TBS. The membranes were incubated for 30 minutes with 
biotinylated goat anti-human IgE (Vector, Burlingame, CA, USA) diluted 1:1000 or 
biotinylated species-specific whole anti-rabbit Ig from donkey (Amersham Life Science, 
Buckinghamshire, UK) diluted 1:5000 in 5% milk-TBS. Alkaline phosphatase conjugated to 
streptavidin (Zymed, San Francisco, CA, USA) diluted 1: 24 000 in TBS was added and 
incubated for 30 minutes. The membranes were placed in an alkaline phosphatase color 
development buffer (Bio-Rad) and rinsed after 10 minutes with tap water.  
 
In immunoblot inhibition, the proteins were electrophoresed and transferred to PVDF 
membranes as described above. Anti-ω-5-gliadin-specific rabbit serum (50 µl, diluted 1:5000 
in TBS) was incubated with an equal volume of inhibitor solution, containing 0.5 or 50 µg/ml 
ω-5 gliadin, for 1 hour at room temperature. The mixture was added to the membranes in 5% 
milk-TBS; the final dilution of the rabbit serum was 1:50 000. Further steps were performed 
as described above. 
 
7.8.2 ELISA (I-V) and ELISA inhibition (I, II, V) 
The concentration of purified cereal proteins (ω-5 gliadin, α-gliadin, γ-secalins or γ-hordein) 
was adjusted to 2 µg/ml and that of crude protein extracts to 15 or 20 µg /ml in 50 mM sodium 
carbonate buffer, pH 9.6, before applying them on 96-well polystyrene microtiter plates (100 
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µl/well) (Nunc, Roskilde, Denmark). In study V, 100 µl of carbonate buffer, containing 50 µl 
of each gel filtration fraction of the untreated and tTG-treated peptic fraction B, was used for 
coating. The plates were incubated at room temperature for 3 hours and then at +4˚C 
overnight. All other steps were performed at room temperature. The wells were blocked with 
100 µl of 1% human serum albumin (HSA) in coating buffer for 1 hour. Individual or pooled 
patient or control sera were diluted 1:150 for IgG1, 1:80 for IgG2, 1:40 for IgG3, 1:20 for 
IgG4, 1:60 for IgA and 1:10 for IgE in PBS, pH 7.4 containing 0.05% Tween and 0.2% HSA. 
Of the diluted sera, 100 µl was applied per well, and the plates were incubated for 2 hours. 
This was followed by incubation for 1 hour with biotinylated mouse anti-human IgG1, IgG2, 
IgG3, IgG4, IgA (Zymed, diluted 1:1000) or biotinylated goat anti-human IgE (Vector, 
diluted 1:1000). Streptavidin-conjugated alkaline phosphatase (Zymed, diluted 1:1000) was 
then added and incubated for 1 hour. Finally, the color substrate solution containing p-
nitrophenyl phosphate (Sigma) was applied; the optical density was measured at 405 nm with 
an automated ELISA reader (Titertek Multiscan, Eflab, Turku, Finland). The mean optical 
density value plus three standard deviations of the control sera were used as the cut-off limit 
for positivity. 
 
In ELISA inhibition, individual or pooled patient sera were preincubated for one hour with 
serial ten-fold dilutions of inhibitor solution (concentrations ranging from 0.0005 to 100 
µg/ml) before applying them to the microtiter plate. All other steps were performed as 
described above for ELISA. 
 
7.8.3 Wheat RAST (I, III) and total IgE (I) 
A commercial immunoCAP method (Pharmacia) was used to measure total and wheat-
specific IgE antibody levels in serum. These measurements were performed routinely in a 
clinical laboratory. 
7.9 In vitro tests for basophil and lymphocyte function (IV) 
7.9.1 Basophil histamine release (IV) 
Washed whole blood cell suspensions containing basophils were incubated in calcium PIPES 
(piperazine-N,N1-bis(2-ethanesulfonic acid) buffer with serial dilutions of crude gliadin 
extract or purified ω-5 gliadin (0.1 pg/ml to 100 µg/ml), goat anti-human IgE (Sigma, diluted 
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1:2000), or buffer only at +37˚C for 45 minutes. The control samples were heated at +100˚C 
for 10 minutes for measurement of total blood histamine releasable from the cells. After 
centrifugation for 10 minutes at 700 g (or 2900 g for total histamine), the histamine content of 
the supernatants was measured by a commercial kit (Immunotech, A Beckman Coulter 
Company, Marseille, France). The amount of histamine released after antigen stimulation was 
expressed as the percentage of the amount released by anti-human IgE. 
 
7.9.2 Lymphocyte proliferation (IV) 
Peripheral blood mononuclear cells (PBMC) from 12 patients with WDEIA and 10 control 
subjects were isolated from heparinized venous blood by Ficoll (Nycomed Pharma As, Oslo, 
Norway) density gradient centrifugation. The isolated and washed cells were incubated in 
complete RPMI 1640 medium (Gibco BRL, Paisley, UK) with crude gliadin extract (1 to 500 
µg/ml in 0.1M acetic acid) at +37˚C under 5% CO2 in 96-well microplates (Costar, Corning 
Incorporated, Corning, NY, USA). Purified tetanus toxoid (10µg/ml, National Public Health 
Institute, Helsinki, Finland) and phytohaemagglutinin (0.5%, Murex Biotech Ltd., Dartford, 
England) served as positive controls. After 6 days of culturing, tritiated methyl-thymidine 
(Amersham Life Science) was added, and the plates were incubated for 18 hours. The cells 
were harvested onto glassfiber filters (Tomtec, Hamden, CT, USA); thymidine incorporation 
was measured with a betaplate counter Trilux (Wallac, Turku, Finland). The results were 
expressed as stimulation indexes (uptake of isotope in stimulated culture/uptake of isotope in 
non-stimulated control culture).  
 
To investigate gliadin-specific cytokine mRNA expression, isolated and washed PBMC were 
stimulated on 24-well plates (Costar, Corning Incorporated) in complete RPMI 1640 medium 
(Gibco BRL) in the presence or absence of crude gliadin extract or ovalbumin (Sigma) at a 
concentration of 75 µg/ml in 0.1 M acetic acid. After incubation for 6 or 24 hours in a 
humidified 5% CO2 atmosphere at +37˚C, the cell pellets were collected and suspended in 
Trizol Reagent (Gibco BRL). 
 
7.9.3 RNA isolation, cDNA synthesis and real-time quantitative PCR (IV) 
RNA was extracted according to the manufacturer's instructions from PBMC homogenized in 
Trizol Reagent (Gibco BRL). The concentration and purity of the isolated total RNA was 
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determined by absorbance measurement, and the integrity of ribosomal RNAs was 
demonstrated by electrophoresis on a 1% agarose gel. 
 
cDNA was synthesized from total RNA in a 100 µl reaction mix using MultiScribe

 Reverse 
Transcriptase and random hexamers from the TaqMan Reverse Transcription Reagents 
(Applied Biosystems, Perkin Elmer). Real-time quantitative PCR was performed on an ABI 
PRISM 7700 Sequence Detector System with a commercial TaqManCytokine Gene 
Expression Plate I (Applied Biosystems, Perkin Elmer). The cDNA, converted from 100 ng of 
total RNA isolated from stimulated (sample) or unstimulated (calibrator) PBMC, was applied 
into the wells on the cytokine plate. Each well contained dried primers and probes for the 
detection of one cytokine cDNA target (IL-1β, IL-4, IL-5, IL-10, IFN-γ, or TNF-α) and the 
endogenous 18S rRNA control. The initial steps in the thermal cycler were 2 minutes at +50˚C 
and 10 minutes at +95˚C. Real-time PCR reactions were made up to 40 cycles: 15 seconds at 
+95˚C and 1 minute at +60˚C. The results were expressed as relative units (RU): i.e., the ratio 
of the PCR amplification efficiency of the sample cDNA to that of the calibrator cDNA. 
 
7.10 In vivo tests 
7.10.1 Skin prick test (I-V) 
SPTs were performed on the volar surface of the forearm with a sterile one-peak lancet (ALK 
Abello, Horsholm, Denmark). The wheat SPT suspension was prepared by extracting ground 
wheat grains (1:10 w/v) in physiological saline. The gliadin SPT suspension was prepared by 
dissolving commercially available crude gliadin (Sigma) at a concentration of 1 mg/ml (w/v) 
in a sterile diluent (ALK Abello) containing 40% glycerol and 20% ethanol. Purified cereal 
allergens were tested with serial dilutions at concentrations ranging from 0.05 to 500 µg/ml in 
sterile PBS containing 20% ethanol. Enzymatically treated allergen peptides were dissolved at 
a concentration 50 µg/ml in sterile-filtered Tris-HCl, pH 8 containing 20% ethanol (V). 
Histamine dihydrochloride (10 mg/ml, ALK) was used as a positive control. Physiologic 
saline (I-V), ethanol-PBS (I-III), and ethanol-Tris-HCl (V) served as negative controls. The 
wheal area was measured after 15 minutes; a diameter at least 3 mm larger than the negative 
control and at least half the diameter of the histamine reaction was considered positive. The 
SPT solutions were stored at -20˚C. 
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7.10.2 Oral wheat challenge (III) 
Physician-supervised oral wheat challenges were performed in 40 children after strict dietary 
avoidance of wheat for 2 to 4 weeks. The open challenge was performed in 27 children. It 
started with application of wheat porridge (10% wheat, cooked in water) on intact facial skin 
and the upper lip. Increasing amounts (1 g, 5 g and 10 g) of wheat were given orally at one-
hour intervals. If no symptoms appeared, the challenge was continued for one week by giving 
a daily dose of at least 20 g of wheat. In double-blind, placebo-controlled wheat challenges, 
performed in 11 children, the placebo formula was amino acid derived Neocate (SHS Int. 
Ltd., Liverpool, UK) and the test formula contained 5 g of wheat flour in 100 ml of Neocate. 
On day 1, the formula was given in increasing amounts (1 ml, 5 ml, 10 ml, 25 ml and 50 ml) 
at 30-minute intervals. If no adverse reactions appeared, the challenge was continued for one 
week the daily intake being 100 ml. On day 8, the second test formula was started by using 
the same challenge protocol. In both challenge procedures, the supervising physician 
examined the child on appearance of any symptoms. The challenge was stopped when 
objective signs and symptoms indicated a positive response (Table 1 in Study III). 
 
7.10.3 Exercise challenge (I) 
The exercise challenge was performed by cycling for 30 minutes on a bicycle ergometer. The 
load was increased from 60 to 100 W with a maximal pulse rate of 120 / min. Forced 
expiratory volume values were monitored, and the lungs were auscultated for wheezing. The 
skin was examined for presence of urticarial wheals. 
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8. RESULTS 
8.1 Clinical features of WDEIA (I, II, IV, V) 
The study comprised a series of 32 adult patients with WDEIA. All had experienced systemic 
allergic symptoms when exercising after wheat ingestion. The triggering factors and clinical 
symptoms reported by the patients are compiled in Table 1.  
 
Table 1. Clinical features and triggering factors in 32 patients with WDEIA 
Patient 
No 
Sex Age (years) 
at 
Food* Exercise* Symptoms* Study no 
  Onset Dg     
1 F 30 32 Bread, pizza Walking, dancing U, R, H, C I, II, IV, V 
2 M 22 35 Bread Walking U, A, D, C I, II, IV, V 
3 M 28 32 Pasta Walking U, A, R, H, C I, II, IV, V 
4 M 31 37 Bread Walking U, D, C I, II, IV, V 
5 M 49 49 Pizza Badminton U, E, R, H, C I, II, IV, V 
6 M 20 48 Bread Indoor floorball U, A, H, C I, II, IV 
7 F 18 26 Muesli Jogging U, A, R, H, C I, II, IV 
8 F 20 24 Hamburger Cycling U, A, R, C I, II, IV, V 
9 M 39 43 Bread Cycling, walking U, A, H, C I, II, IV, V 
10 M 20 24 Doughnut Squash U I, II, IV 
11 F 36 37 Pie Walking U, H, C I, II, IV 
12 F 59 77 Cookies Walking U, H, C I, II, IV 
13 M 30 45 Pizza Golf U, H, C I, II, IV 
14 M 56 59 Bread Running U, D I, II, IV 
15 M 30 42 Bun Jogging U, H, C I, II, IV 
16 M 32 36 Bread Jogging U, A, H, C I, II, IV 
17 F 36 39 Bread Running U, A, H, C I, II, IV, V 
18 F 25 34 Pasta, pizza Skiing, walking U, A, H ,C I, II, IV, V 
19 F 31 40 Pasta Walking U, A, H II, IV, V 
20 M 46 47 Bread Jogging U, A, H, C II, IV, V 
21 M 66 66 Pizza Construction work U, A, H, C II, IV, V 
22 F 43 52 Bread Walking U, A, R, H, C II, IV 
23 M 32 32 Pancake Walking U, A, H II, IV 
24 M 43 44 Hamburger Running U, A, D IV, V 
25 F 41 43 Pizza Jogging U, A, D IV, V 
26 F 42 46 Bread Walking U, C IV 
27 M 22 26 Bread Jogging U, A, H, C IV, V 
28 M 21 24 Bun Walking U, A, D, C V 
29 F 27 29 Pizza Jogging U, A, D, C V 
30 F 27 28 Toast Walking U, A, D V 
31 M 54 55 Bread Running U, R, H, C V 
32 M 26 29 Toast Ice hockey U, A, H, C V 
* Causing the most severe reaction; U = generalized urticaria; A = angioedema; R = 
respiratory distress; D = dizziness; H = hypotension; C = collapse 
 
The level of physical exertion provoking symptoms showed considerable variation, ranging 
from light indoor activities and walking to more strenuous exercise, such as bicycling, 
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jogging, skiing, dancing, and ball games. The time between wheat ingestion and the 
beginning of exercise varied from 10 minutes to 4 hours, and the duration of exercise before 
the onset of symptoms from 10 minutes to about 1 hour. The prodromal symptoms included 
pruritus, flushing, and erythema of the skin. This was followed by urticarial wheals that 
developed rapidly into generalized urticaria, angioedema, and dyspnea. In more advanced 
reactions the patients collapsed. Generalized urticaria was the main symptom, present in all 
patients. In 21 (66%) patients it was accompanied by angioedema and in seven (22%) patients 
by respiratory distress. Hypotension was documented in 21 (66%) patients, whereas 9 (28%) 
patients reported dizziness (blood pressure not taken). The reaction progressed to vascular 
collapse in 25 (78%) patients. The number of anaphylactic episodes ranged from one to ten 
per year (Table 1 in Study I). 
  
8.2 Dietary treatment of patients with WDEIA (I) 
After diagnosis of WDEIA, the patients were advised to start a gluten-free diet, i.e., to avoid 
wheat, rye, barley, and oats, because of possible cross-reactions between these closely related 
cereals (Varjonen et al. 1997). Of the 18 patients in Study I, 13 adhered to a gluten-free diet, 
three to a wheat-free diet, and two patients avoided wheat several hours before exercise 
(Table 3 in Study I). Owing to the anxiety caused by severe anaphylaxis, one patient gave up 
exercising; all others continued their earlier exercise regimens. During the follow-up (mean 
20 months), two patients on a wheat-free diet and one on a gluten-free diet experienced 
reactions after inadvertent wheat ingestion before walking, bicycling, or jogging. All three got 
generalized urticaria, and one patient collapsed. The two patients who avoided wheat only 
prior to exercise experienced annually one to three urticaria reactions. Being aware of the 
condition, they discontinued the exercise and took their medication at the earliest symptoms. 
 
8.3 Antibody responses to wheat proteins in WDEIA and childhood wheat allergy 
8.3.1 Characterization of the IgE response in WDEIA and purification of wheat allergens  
 
Immunoblotting, allergen purification, and sequencing (I) 
Wheat proteins, extracted with 50% ACN containing 0.1% TFA, were separated into two 
fractions according to solubility in ACN (Figure 1). Immunoblotting with pooled sera from 11 
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patients with WDEIA was used to detect the IgE-binding proteins. A protein from the ACN-
soluble extract with an apparent molecular weight of 65 kDa in SDS-PAGE and a protein 
from the water/TFA-soluble extract with a molecular weight of 40 kDa showed the strongest 
binding of serum IgE antibodies in immunoblotting. The 65 kDa protein was purified into 
apparent homogeneity by reversed-phase HPLC, and the 40 kDa protein by gel filtration 
HPLC followed by reversed-phase HPLC. The N-terminal sequence 
(SRLLSPRGKELHTPQEQFPQQQQFPQPQQFPQ; 32 amino acids) of the 65 kDa protein 
was not present in the protein sequence databanks, but it showed 61% identity to wheat γ-
gliadin (amino acids 65-101). This protein was therefore called γ-like gliadin; later it was 
named ω-5 gliadin according to the N-terminal sequence (22 amino acids) described by 
Kasarda et al. (1983). The WHO/IUS Allergen Nomenclature Sub-Committee named ω-5 
gliadin as Tri a 19. The sequence (VRVPVPQLQPQNPSQQQPQEQV; 22 amino acids) of 
the 40 kDa protein was identical to that of wheat α-gliadin. 
 
IgE ELISA (I, IV) 
The IgE-binding ability of the purified proteins was studied by ELISA. In Study I, all 18 
patients with WDEIA had IgE antibodies to purified ω-5 gliadin and 13 patients to α-gliadin. 
None of the 54 controls with wheat allergy, urticaria, or celiac disease had IgE to ω-5 gliadin. 
One wheat-allergic control with baker’s asthma and one with occupational allergic rhinitis 
had slightly elevated IgE levels to α-gliadin (Figure 2 in Study I). Similarly, sera from 27 
patients with WDEIA in study IV showed IgE binding to purified ω-5 gliadin and commercial 
crude gliadin (Sigma) in ELISA, whereas 21 control subjects without wheat allergy remained 
negative for both allergens (Figure 1 in Study IV).   
 
Skin prick testing (I, II, V) 
Altogether 28 of the 32 patients with WDEIA underwent SPTs with purified ω-5 gliadin (I, II, 
V). At a concentration of 50 µg/ml, ω-5 gliadin elicited SPT reactions at least the size of the 
histamine control in all 28 patients with WDEIA. In the 15 patients tested in Study I, the 
concentration of ω-5 gliadin causing a wheal at least the size of histamine was 0.05 µg/ml in 
three, 0.5 µg/ml in four, 5 µg/ml in four, and 50 µg/ml in four patients. In the same study, 
commercial crude gliadin (1 mg/ml, Sigma) caused positive SPT reactions in all 15 patients, 
but purified α-gliadin only in five of the patients at the highest concentration (500 µg/ml) 
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tested (Table 2 in Study I). Six controls (3 non-atopic and 3 atopic adults with wheat flour 
allergy) gave negative SPT results to the purified and crude gliadins.  
 
Figure 1. Identification and purification of IgE-binding wheat proteins 
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ELISA inhibition (I) 
In ELISA inhibition, ω-5 gliadin (100 µg/ml) inhibited up to 80%, but α-gliadin less than 
15%, of the IgE binding in pooled patient sera to solid-phase wheat proteins in the water/TFA 
extract (Figure 3 in Study I). ω-5 gliadin (50 µg/ml) inhibited dose-dependently nearly 100% 
of the IgE binding in pooled sera (n=9) to crude gliadin (15 µg/ml, Sigma) on solid-phase and 
approximately 50% of the IgE binding to a PBS extract of wheat (15 µg/ml) (Figure 2, 
unpublished results). The pooled sera gave 80% higher IgE values in ELISA for crude gliadin 
(optical density 0.56 at 405 nm) than for the PBS wheat extract (optical density 0.31 at 405 
nm) (unpublished results).  
 
Figure 2. ELISA inhibition of IgE binding in pooled sera from nine patients with WDEIA to 
crude gliadin (closed circles) and a PBS extract of wheat (open circles) on solid-phase with 
different concentrations of purified ω-5 gliadin (0.005-50 µg/ml). 
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8.3.2 Allergen-specific IgA and IgG responses in WDEIA (IV) 
Sera from 27 patients with WDEIA and 21 controls without wheat allergy were examined for 
the presence of IgA and IgG subclass antibodies to purified ω-5 gliadin (2 µg/ml) and crude 
gliadin (20 µg/ml). Although IgA antibodies to these allergens were detected both in patient 
and control sera, the mean IgA levels to ω-5 and crude gliadin were significantly higher in the 
sera of patients (mean ELISA values 0.68 and 1.0) than in the sera of controls (mean ELISA 
values 0.38 and 0.74, P < 0.01 and P < 0.001, unpaired t-test) (Figure 2 in Study IV).  
 
The distribution of IgG subclass antibodies to ω-5 and crude gliadin was similar in sera from 
patients with WDEIA and control sera. IgG3 levels to ω-5 gliadin were slightly elevated in 
the patients (mean ELISA value 0.22), but compared with the controls (mean ELISA value 
0.11), the difference was statistically insignificant. Levels of IgG1, IgG2 and IgG4 antibodies 
to ω-5 gliadin were low, both in patients and controls (mean ELISA values 0.05, 0.03, and 
0.15 for WDEIA, and 0.04, 0.15, and 0.03 for controls, respectively). The range of IgG1-4 
antibody levels to crude gliadin (mean ELISA values 0.17, 0.32, 0.33, and 0.52 for WDEIA 
patients, and 0.23, 0.56, 0.30, and 0.54 for controls, respectively) was large and overlapped 
extensively between the two groups, showing no significant differences. 
 
8.3.3 IgE reactivity to purified ω-5 gliadin in children with wheat allergy (III) 
Sera from 40 children with suspected wheat allergy were examined for the presence of IgE 
antibodies to purified ω-5 gliadin. Clinical reactivity to wheat was assessed with open or 
double-blind, placebo-controlled oral wheat challenge. In the challenge, 19 (48%) of the 40 
children reacted with immediate hypersensitivity symptoms, including urticaria, erythema, 
upper and lower respiratory, and abdominal symptoms (Table I in Study III). One child 
experienced anaphylaxis requiring emergency medication. Eight children (20%) reacted with 
delayed symptoms showing exacerbation of atopic dermatitis or gastrointestinal symptoms, 
such as diarrhea (Table I in Study III). Thirteen (32%) children developed no symptoms in 
response to the wheat challenge. 
 
From the group of 19 children with immediate challenge symptoms, 16 (84%) had serum IgE 
antibodies to purified ω-5 gliadin in ELISA (Figure1 and Table I in Study III). In contrast, 
IgE antibodies to ω-5 gliadin were not present in the eight children with delayed symptoms, 
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or in the 13 children with a negative challenge. Sera from 22 additional control children 
without food allergy showed no IgE binding to ω-5 gliadin in ELISA. SPTs with purified ω-5 
gliadin were carried out in seven children from the immediate challenge group and in two 
children from the delayed challenge group. Six of the seven children with immediate 
symptoms gave positive SPT responses to all three concentrations of ω-5 gliadin (5, 50, and 
500 µg/ml) tested (Table I in Study III), and the two children with delayed symptoms had 
negative SPTs to ω-5 gliadin. All six children with a positive SPT had also IgE antibodies to 
ω-5 gliadin in ELISA, whereas the three children with a negative SPT were negative in 
ELISA. ELISA inhibitions were performed with pooled sera from nine children with 
immediate challenge symptoms (unpublished results). Purified ω-5 gliadin (50 µg/ml) 
inhibited 20% of the IgE binding to solid-phase crude gliadin (15 µg/ml) and less than 5% of 
the IgE binding to the water/salt-soluble PBS extract of wheat (15 µg/ml) on solid-phase. 
 
Both the diagnostic specificity and the positive predictive value of ω-5 gliadin IgE ELISA 
were 100% for immediate challenge reactions. The corresponding values for commercial 
wheat CAP RAST (67% and 72%) or wheat SPT (71% and 74%) were considerably lower 
(Table II in Study III). None of the 13 challenge-negative children had IgE antibodies to ω-5 
gliadin, conversely five (38%) had a positive wheat CAP RAST and five (38%) showed 
positive SPTs to wheat (Table I in Study III).  
 
8.4 Characterization of allergens in rye, barley, and oats cross-reacting with ω-5 
gliadin in WDEIA (II) 
Proteins from rye, barley, and oats were extracted sequentially with PBS and 75% ethanol. 
Allergens cross-reacting with wheat ω-5 gliadin were identified by immunoblot inhibition 
using rabbit antiserum raised against ω-5 gliadin and pooled sera from patients with WDEIA. 
The rabbit antiserum identified 32 kDa and 70 kDa proteins in the ethanol-soluble extract of 
rye and a 34 kDa protein in the ethanol-soluble extract of barley. The binding was completely 
inhibited by 50 µg/ml and partly by 0.5 µg/ml of purified ω-5 gliadin in immunoblot 
inhibition (Figure 1 in Study II). The rabbit antiserum did not recognize proteins in oats or the 
salt-soluble cereal extracts. The 32, 34, and 70 kDa proteins were also the major allergens 
detected by IgE antibodies in pooled patient sera.  
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The cross-reactive rye and barley proteins were purified into apparent homogeneity by gel 
filtration and reversed-phase HPLC (Figure 2 in Study II). The N-terminal sequence of the rye 
70 kDa protein (NMQVNPSGQVQWPQQQPFPQ; 20 amino acids) was identical to that of 
rye γ-70 secalin. The rye 32 kDa protein (NMQVGPSGQVEWPQQQPLPQPQQ; 23 amino 
acids) showed 96% identity to rye γ-35 secalin, and the barley 34 kDa protein 
(ITTTTMFNPSGLELERPQQLFPQW; 24 amino acids) was identified as barley γ-3 hordein. 
 
Cross-reactivity was further examined by ELISA and ELISA inhibition. Of the 23 patients 
with WDEIA, 21 (91%) showed serum IgE binding to γ-70 secalin, 19 (83%) to γ-35 secalin, 
and 21 (91%) to γ-3 hordein (Figure 3 in Study II). One patient with baker’s asthma had IgE 
to the rye γ-secalins and one wheat-allergic patient to barley γ-3 hordein. All the other 40 
control subjects were negative. In ELISA inhibition, ω-5 gliadin (100 µg/ml) inhibited in a 
dose-dependent manner over 90% of the IgE binding of pooled patient sera to solid-phase γ-
70 and γ-35 secalins, and to γ-3 hordein. When the γ-secalins and γ-3 hordein were used as 
inhibitors (100 µg/ml), and ω-5 gliadin was on solid-phase, the inhibition was about 50% 
(Figure 4 in Study II). ω-5 gliadin (100 µg/ml) inhibited also over 90% of the rabbit antiserum 
IgG binding to solid-phase γ-secalins and γ-3 hordein. In crosswise inhibitions, γ-70 secalin 
inhibited over 50% of the IgG-binding to solid-phase ω-5 gliadin, but γ-35 secalin or γ-3 
hordein caused no significant inhibition (data not shown). 
 
SPTs with the purified rye and barley proteins were carried out in 15 patients with WDEIA at 
three different concentrations (5, 50, and 500 µg/ml). γ-70 secalin (500 µg/ml) elicited 
positive SPT reactions in 10 (67%) patients, γ-35 secalin in three (20%) patients, and γ-3 
hordein in seven (47%) patients (Table 1 in Study II). All 15 patients tested gave positive 
reactions to ω-5 gliadin (50 µg/ml). The WHO/IUS Allergen Nomenclature Sub-Committee 
named γ-70 secalin as Sec c 20.01, γ-35 secalin as Sec c 20.02, and γ-3 hordein as Hor v 21. 
 
8.5 Allergen-specific cellular responses in WDEIA (IV) 
To measure allergen-specific histamine release, basophils in whole blood from nine patients 
with WDEIA and five non-allergic controls were stimulated with serial dilutions of crude and 
purified ω-5 gliadin. Both allergens released high levels of histamine from the basophils of 
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patients with WDEIA, but not from those of control subjects (Figure 3 in Study IV). The 
antigen concentration inducing maximal histamine release showed individual variation, 
ranging from 0.1 pg/ml to 10 µg/ml. The highest histamine release value was chosen for 
calculation of results. The mean histamine release induced by ω-5 gliadin was 47.6% in the 
patients and 4.5% in the controls, expressed as percentages of anti-IgE-induced histamine 
release. The corresponding values for crude gliadin were 35% and 3.4% (P < 0.001, Mann-
Whitney U test). 
 
PBMC from 12 patients with WDEIA and 10 controls were stimulated for 6 days with 
different concentrations of crude gliadin. Proliferative responses to crude gliadin (50 µg/ml) 
were significantly (P < 0.01, Mann-Whitney U test) greater in patients with WDEIA than in 
controls, although they overlapped to some extent between the groups (Figure 4 in Study IV). 
The mean stimulation indexes were 3.80 for patients and 1.44 for controls. Proliferative 
responses to tetanus toxoid and phytohaemagglutinin showed no differences between the two 
groups. 
 
Gliadin-induced cytokine mRNA expression was screened in PBMC of five patients with 
WDEIA and five controls. Gliadin-specific IL-10 mRNA expression was studied in five 
additional patients and five additional controls, and ovalbumin-specific IL-10 expression in 
five patients and five controls. Stimulation of isolated and washed PBMC for 6 hours with 
crude gliadin (75 µg/ml) induced, both in patients and controls, clear IL-10 mRNA expression 
(Figure 5 in Study IV). The IL-10 mRNA levels were, however, significantly lower in the 
patients (P < 0.01, unpaired t-test). The mean gliadin-specific IL-10 mRNA levels in relative 
units were 81.7 in the patients compared with 156.8 in the controls. Ovalbumin-specific IL-10 
mRNA expression showed no differences between the two groups. Gliadin stimulation 
induced no significant expression of Th2-type (IL-4, IL-5), Th1-type (IFN-γ), or 
proinflammatory (IL-1β, TNF-α) cytokines in patients or controls. No significant differences 
in the levels of any cytokines were observed after 24 hours' stimulation (data not shown). 
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8.6 Effects of digestion and tTG treatment on the in vitro and in vivo IgE reactivity to 
ω-5 gliadin in WDEIA (V) 
Mimicking enzymatic digestion of food proteins in the gastrointestinal tract, purified ω-5 
gliadin was digested with pepsin or with pepsin and trypsin. After digestion, the peptides were 
treated with tTG, a multifunctional, cross-linking enzyme localized beneath the gut 
epithelium. The binding of serum IgE antibodies to the digests, before and after tTG 
treatment, was studied by immunoblotting. Pooled sera from 10 patients with WDEIA showed 
clear IgE binding to pepsin-digested ω-5 gliadin (whole peptic digest) (Figure 1 in Study V). 
Subsequent tTG treatment of the digest formed large peptide complexes with molecular 
masses ranging from 40 to over 200 kDa. These cross-linked aggregates bound serum IgE 
antibodies in immunoblotting more intensely than pepsin-digested or intact ω-5 gliadin. 
Consecutive pepsin and trypsin digestion of ω-5 gliadin produced smaller peptides, most of 
which were not visible in immunoblotting. These peptides were cross-linked by tTG to a 
lesser extent than those in the whole peptic digest, and the cross-links showed weaker IgE 
binding in immunoblotting (Figure 1 in Study V). Albumin (Sigma) served as a control 
protein in immunoblotting; no IgE binding was detected after digestion and tTG treatment of 
albumin according to the same protocol used for ω-5 gliadin. Neither pepsin nor pepsin and 
trypsin bound IgE in immunoblotting before or after treatment with tTG (data not shown).  
 
Gel filtration HPLC was used to fractionate the peptides in the whole peptic digest of ω-5 
gliadin (Figure 2A in Study V). IgE reactivity of four different peptide fractions (A-D) was 
studied by immunoblotting before and after tTG treatment (Figure 2B in Study V). Of these 
peptide fractions, the first three were cross-linked by tTG (Figure 2C in Study V). The 
greatest degree of tTG-mediated cross-linking, as well as the most intense IgE binding in 
immunoblotting, was observed for the gel filtration fraction B, corresponding to the highest 
peak of the chromatogram and thus to the largest amount of protein. This fraction B was 
further studied by ELISA, ELISA inhibition, and SPT. 
 
The purified peptic fraction B and an equivalent amount of the same fraction after tTG 
treatment were subjected to gel filtration HPLC to further examine the cross-linked 
complexes formed by tTG. Gel filtration fractions were separated according to size, and their 
IgE-binding ability was compared in ELISA. tTG treatment created a protein peak that eluted 
earlier, and was not present in the chromatogram of  the untreated peptic fraction B (Figure 
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3A in Study V). IgE in pooled patient sera (n=10) showed clear binding to this protein peak in 
ELISA as well as higher IgE values to all fractions after tTG treatment (Figure 3B in Study 
V). When tTG alone was subjected to gel filtration under the same conditions, the patient sera 
showed no IgE binding in ELISA to any of the gel filtration fractions (data not shown). In 
ELISA inhibition, intact ω-5 gliadin (0.005 to 50 µg/ml) inhibited in a dose-dependent 
manner up to 95% of the IgE binding in pooled patient sera to the tTG-treated peptic fraction 
B on solid-phase, and vice versa (Figure 4 in Study V). An almost identical inhibition curve 
was observed, when IgE binding to solid-phase ω-5 gliadin was inhibited with ω-5 gliadin 
itself. 
 
SPTs (50 µg/ml) were performed in 20 patients with WDEIA to assess in vivo IgE reactivity 
to the digested and tTG-treated peptides. In 18 of these patients, the tTG-treated peptic 
fraction B gave a larger SPT reaction than the untreated peptic fraction B (Figure 5A in Study 
V). The mean wheal area of the tTG-treated peptic fraction B (53 mm2) was 77% larger (P < 
0.001, Wilcoxon matched pairs test) than that of the untreated peptic fraction B (30 mm2) and 
56% larger (P < 0.01, Wilcoxon matched pairs test) than that of intact ω-5 gliadin (34 mm2) 
(Figure 5B in Study V). The mean SPT wheal area elicited by intact ω-5 gliadin was 1.8-fold 
larger than that of histamine (19 mm2), used as a positive control. The peptic fraction B 
caused a slightly smaller reaction than ω-5 gliadin, being 1.6-fold larger than the histamine 
reaction. However, being 2.8 times the size of the histamine control, the SPT reaction elicited 
by the tTG-treated peptic fraction B was very large. Although the mean wheal areas of the 
whole peptic digest (30 mm2) and the peptic-tryptic digest (30 mm2) increased slightly after 
tTG treatment (34 and 36 mm2, respectively), the differences were statistically insignificant 
(data not shown). SPT responses to tTG were negative in all patients and controls. The three 
control patients with ingested wheat allergy not related to exercise gave positive reactions to 
intact ω-5 gliadin (mean wheal area 20 mm2), but were negative to the untreated and tTG-
treated peptic fraction B. SPTs were completely negative in the patient with exercise-induced 
anaphylaxis not related to food ingestion. 
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9. DISCUSSION 
9.1 Clinical aspects of WDEIA 
This study describes 32 patients with WDEIA, which is thus far the largest series of such 
patients reported internationally. It shows that wheat is a common cause of FDEIA in the 
Finnish population. This series of patients, together with reports from other countries (e.g., 
Japan, France, and Italy), suggest that the prevalence of WDEIA may be higher than 
previously assumed (Dohi et al. 1991, Guinnepain et al. 1996, Romano et al. 2001, Aihara et 
al. 2002, Chong et al. 2002). The reports come, however, from a relatively small number of 
countries, suggesting that WDEIA is a poorly recognized cause of recurrent anaphylaxis in 
adults. The first five cases of WDEIA in Finland were reported in 1997 (Varjonen et al. 
1997). Since then, patients referred to the Helsinki University Hospital because of exercise-
induced allergic reactions, have been screened for the presence of food allergies. Increased 
awareness, as well as improved diagnostics, led to the recognition of several cases of WDEIA 
each year during a five-year period. Although studies from other countries have implicated 
foods, such as tomato, seafood, and tree nuts, in FDEIA (Guinnepain et al. 1996, Shadick et 
al. 1999, Romano et al. 2001), we did not come across cases of FDEA elicited by foods other 
than wheat. 
 
The diagnosis of WDEIA was based on a convincing clinical history of EIA after ingestion of 
wheat products, a positive SPT response to wheat, and the resolution of symptoms after 
introduction of a gluten-free or wheat-free diet. Exercise challenges were performed without 
food ingestion to rule out classic EIA, but challenges were not carried out after wheat 
ingestion, because of the risk for severe reactions. Moreover, dietary avoidance of gluten led 
to symptom resolution. Earlier studies have demonstrated severe anaphylactic reactions in 
patients with WDEIA after combined wheat and exercise challenges (Katsunuma et al. 1992, 
Juji et al. 1994). On the other hand, such challenges in a laboratory setting may fail to 
reproduce symptoms (Dohi et al. 1991, Fukutomi et al. 1992, Romano et al. 1995), and thus a 
negative challenge result does not rule out the presence of FDEIA. Two recent reports 
demonstrated that aspirin facilitated the development of wheat-induced symptoms during 
exercise provocation tests, and that combined wheat and aspirin ingestion was able to trigger 
symptoms in patients with WDEIA, even without exercise (Harada et al. 2001, Aihara et al. 
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2002). Nevertheless, aspirin intake was not related to symptoms of WDEIA in any of our 
patients. 
 
All of the 32 patients in our study were adults, their mean age being 34 (range 18 to 66 years) 
at the onset of symptoms. In many patients, WDEIA was diagnosed only after a considerable 
delay; the mean age at diagnosis was 40 (range 24 to 66 years). None of the patients had 
suffered from wheat allergy in childhood, and other atopic diseases, such as allergic rhinitis, 
atopic dermatitis, or asthma, were present only in a minority of the patients. The development 
of WDEIA in our patients seemed thus unrelated to an atopic constitution or a history of 
cereal allergy in childhood. In a series of 12 Japanese patients with WDEIA, the mean age at 
onset was 24 (range 10 to 63 years), and 67% had an atopic constitution (Aihara et al. 2002).  
 
9.2 ω-5 gliadin as a major allergen in WDEIA 
The present study showed that patients with WDEIA have IgE antibodies against gliadins, the 
ethanol-soluble storage proteins of the wheat grain. This is in agreement with earlier studies 
by Kushimoto and Aoki (1985) and by Varjonen et al. (1997), where the major IgE-binding 
proteins recognized in immunoblotting were the ethanol-soluble gliadins. We examined IgE 
binding to two purified wheat allergens, identified as α-gliadin and ω-5 gliadin. IgE 
antibodies to purified ω-5 gliadin were detected by ELISA and / or SPTs in all 32 patients.  In 
ELISA, ω-5 gliadin bound IgE from altogether 27 WDEIA patient sera (IV). It elicited 
positive SPT responses at a concentration of 50 µg/ml in a total of 28 patients (I, II, V). The 
four patients not examined by SPTs had serum IgE antibodies to ω-5 gliadin in ELISA (IV). 
The finding that ω-5 gliadin induced high histamine release from the basophils of patients 
with WDEIA further supports the clinical significance of this allergen (IV). Although purified 
α-gliadin was recognized by IgE in 13 (72%) of the 18 WDEIA patient sera, it elicited 
positive SPT responses at a concentration of 500 µg/ml in only five (33%) of the 15 patients 
tested (I). 
 
In vitro methods, such as immunoblotting and ELISA, detect the binding of one IgE molecule 
to the allergen. In contrast, positive SPT responses and histamine release from basophils 
require allergen-induced cross-linking of two IgE molecules bound to high affinity receptors 
on mast cells or basophils. ω-5 gliadin gave positive SPT responses at significantly lower 
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concentrations than α-gliadin, suggesting differences in epitope valency or a lower affinity of 
IgE to α-gliadin. As gliadins share a great degree of sequence and structural homology 
(Shewry and Tatham 1990), it is possible that IgE binding to α-gliadin results from 
immunologic cross-reactivity to ω-5 gliadin. ELISA inhibition experiments to clarify this 
matter were not performed because of limited antigen availability.  
 
The full amino acid sequence of ω-5 gliadin is unknown, and its IgE-binding epitopes have 
not been characterized.  Unfortunately, attempts to identify internal sequences of ω-5 gliadin 
after tryptic digestion were unsuccessful (unpublished results). Nevertheless, ω-gliadins are 
known to consist almost entirely of repeating sequence motifs rich in proline and glutamine 
amino acids (Kasarda et al. 1983). It may be speculated that the high allergenic potential of ω-
5 gliadin could result from the presence of a large number of IgE-binding epitopes in these 
repeating sequences. Similar epitopes could be present in many other gliadin proteins as well, 
but possibly in smaller amounts. As the total number of gliadins is above 40 (Shewry and 
Miflin 1985), it is highly probable that other proteins in this structurally similar gliadin group 
also bind IgE from the sera of patients with WDEIA. Recently, Morita et al. (2001) 
demonstrated by immunoblotting serum IgE binding to γ-gliadin in four Japanese patients 
with WDEIA, but SPT reactivity to purified γ-gliadin was not examined. RAST inhibition 
with γ-gliadin (200 µg/ml) purified from a commercial gluten extract was able to inhibit 60 to 
90% of serum IgE binding to solid-phase gluten proteins.  
 
To further characterize the IgE response in WDEIA, ELISA inhibition studies were performed 
with pooled patient sera. ω-5 gliadin (100 µg/ml) was able to inhibit 80%, but α-gliadin (100 
µg/ml) only about 15%, of the IgE binding to the water/TFA extract of wheat on solid-phase 
(I). This extract contained mainly water/salt-soluble proteins in addition to some acid-soluble 
gliadins and glutenins. When IgE binding to solid-phase crude gliadin (Sigma), a 
commercially available mixture of the ethanol-soluble wheat proteins, was inhibited with ω-5 
gliadin (50 µg/ml), the inhibition percent was nearly 100% (unpublished results). This 
suggests that structurally similar epitopes, shared by ω-5 gliadin and the various gliadin 
proteins in the crude extract, are responsible for the IgE binding to wheat gliadins. Compared 
with the crude gliadin extract, IgE ELISA values to the water/salt-soluble PBS extract of 
wheat were low, and ω-5 gliadin (50 µg/ml) inhibited up to 50% of this binding (unpublished 
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results). It seems therefore likely that the water/salt-soluble extracts of wheat contain small 
amounts of proteins with IgE-binding epitopes different from those in ω-5 gliadin. 
 
Both ω-5 and α-gliadin meet the criteria for a major allergen, when defined as a protein that 
binds IgE antibodies in more than 50% of patient sera responding to the whole allergen 
extract (Liebers et al. 1996). This definition does not, however, take into account the fact that 
the presence of specific IgE in serum does not necessarily correlate with clinical reactivity. 
The term "complete allergen" introduced by Aalberse (2000) requires that the allergen not 
only binds IgE, but is also able to sensitize and elicit clinical symptoms on re-exposure. Of 
the two allergens studied only ω-5 gliadin seems to fulfil the criteria for a complete allergen. 
 
9.3 Significance of ω-5 gliadin in childhood wheat allergy  
Study III examined the clinical significance of ω-5 gliadin as an allergen in 40 children with 
suspected wheat allergy by comparing results of oral wheat challenges with IgE reactivity 
against purified ω-5 gliadin. The presence of IgE antibodies to ω-5 gliadin associated strongly 
with immediate symptoms on oral wheat challenge, but not with delayed symptoms or 
negative challenges (III).  
 
The finding that the same allergen binds IgE antibodies both in children with immediate 
wheat allergy and adults with WDEIA is rather unexpected, because the clinical 
manifestations in these two forms of wheat allergy are clearly different. Most wheat-allergic 
children are highly atopic, presenting with atopic dermatitis and other food allergies (e.g. milk 
and egg). When challenged with wheat, they react with classic food allergy symptoms of the 
skin, respiratory tract, or gut; the clinical picture ranges from mild, local symptoms to severe 
systemic anaphylaxis (III). On the contrary, adults with WDEIA experience recurrent 
episodes of anaphylaxis provoked by wheat ingestion in connection with exercise, yet wheat 
ingestion alone causes no symptoms (I). In WDEIA, the reactions do not begin until 
adulthood, and the reactivity tends to persist, while most children outgrow their reactivity to 
wheat within a few years (Sicherer and Sampson 1999).  
 
On the contrary, IgE antibodies from patients with inhalant wheat allergy, wheat-induced 
contact urticaria, or children with delayed-type symptoms to ingested wheat did not recognize 
  
 
61 
ω-5 gliadin.  It seems that IgE antibodies against ω-5 gliadin, and gliadin proteins in general, 
are related to sensitization via the gut as well as immediate systemic allergic symptoms after 
wheat ingestion. Supporting this view, Varjonen et al. (2000) showed extensive IgE binding 
and positive SPT responses to the gliadin fraction of wheat in children with immediate 
challenge symptoms, but not in challenge-negative children. In Study III, IgE levels to ω-5 
gliadin were particularly high in two children with a recent history of wheat-induced 
anaphylaxis and in one child who experienced anaphylaxis during the challenge, suggesting 
that ω-5-gliadin-specific IgE may correlate with the severity of systemic symptoms. Takizawa 
et al. (2001) detected IgE binding to 35 - 67 and 95 kDa water/salt-insoluble proteins in the 
sera of seven children with wheat-induced anaphylaxis. Six wheat-allergic children with 
atopic dermatitis showed similar, but less intense, IgE-staining patterns. The allergens in this 
study were not characterized, it is however possible that the IgE-binding proteins around 65 - 
67 kDa could correspond to ω-5 gliadin.  
 
Patients with WDEIA and children with challenge-confirmed wheat allergy gave clearly 
different results in ELISA inhibition studies. ω-5 gliadin (50 µg/ml) inhibited only about 20% 
of the IgE binding in pooled sera of wheat-allergic children to solid-phase crude gliadin, 
compared with a nearly 100% inhibition in WDEIA patient sera. When the water/salt-soluble 
PBS extract of wheat was on solid-phase, the corresponding inhibition percentages were 50% 
for WDEIA patient sera, but less than 5% for the sera of children (unpublished results). This 
suggests that, in addition to ω-5 gliadin, many other water/salt-soluble and insoluble proteins 
bind IgE antibodies from the sera of wheat-allergic children, and that ω-5 gliadin does not 
account for the majority of IgE binding to wheat. This is in line with previous immunoblot 
results showing extensive IgE binding to numerous wheat proteins with molecular masses 
ranging from 15 to 69 kDa (Varjonen et al. 1995, Jones et al. 1995, James et al. 1997). 
However, the various IgE-binding proteins detected by immunoblotting studies have not been 
characterized at the molecular level, and their clinical significance remains unknown.  
 
Nevertheless, the presence of IgE to ω-5 gliadin showed a strong correlation with immediate 
challenge reactions; wheat ingestion elicited clinical symptoms in all 16 children with IgE to 
ω-5 gliadin. IgE ELISA with purified ω-5 gliadin gave a diagnostic specificity and positive 
predictive value of 100% and a sensitivity of 84% for immediate challenge reactions. ω-5 
gliadin gave no false positive results, in contrast to wheat CAP RAST (Pharmacia) and SPT 
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(in 0.9% NaCl), which showed positive results in 38% of the challenge-negative children. The 
children with delayed challenge symptoms were all negative for ω-5 gliadin, a finding that 
could result from the presence of non-IgE-mediated immune mechanisms or the binding of 
IgE antibodies to different wheat proteins in this subset of patients. Detection of IgE 
antibodies to ω-5 gliadin may offer a specific diagnostic test useful in reducing the need for 
potentially dangerous oral challenges, especially in cases of severe wheat allergy.  
 
In earlier studies, the diagnostic accuracy of wheat SPTs and in vitro IgE assays has been 
unsatisfactory (Sampson and Albergo 1984, Räsänen et al. 1994, Sampson and Ho 1997, 
Majamaa et al. 1999, Sporik et al. 2000). A recent study by Sampson (2001) determined 
food-specific IgE levels with the CAP system more than 95% predictive of clinical reactivity. 
However, in the case of wheat the positive predictive value remained less than 75% at a cut-
off value of 26 kU/l. The poor predictive capacity of the commercial test reagents could be 
explained by the fact that they are mixtures of water/salt-soluble wheat proteins lacking 
allergens from the insoluble gliadin fraction. Moreover, cross-reactivity of water/salt-soluble 
wheat proteins with grasses increases the frequency of clinically insignificant positive test 
results (Jones et al. 1995). 
 
The IgE response in wheat-allergic children is complex and directed towards multiple wheat 
proteins. Further studies with purified allergens are required to distinguish clinically 
significant allergens from the clinically irrelevant ones. Whether other soluble or insoluble 
wheat proteins give diagnostic values comparable to those of ω-5 gliadin, remains to be 
elucidated by future studies.  
 
9.4 IgA and IgG antibodies to crude and ω-5 gliadin in WDEIA 
Study IV examined humoral immune responses to gliadin in 27 patients with WDEIA and 21 
control subjects without wheat allergy. In the patients, levels of IgA antibodies to crude and 
ω-5 gliadin were significantly higher than in the controls, although the ranges overlapped to 
some extent. IgA antibodies to gliadin are a marker of intestinal mucosal damage in patients 
with celiac disease (Savilahti et al. 1983), but these antibodies are detected in healthy 
individuals as well (Uibo et al. 1993, McMillan et al. 1996). IgA constitutes 15 to 20% of 
serum immunoglobulins, and it is the main immunoglobulin at mucosal surfaces, where it is 
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involved in protection against microorganisms (van Egmond et al. 2001). It has been 
proposed that serum IgA might provide a second line of defense in mucosal immunity by 
IgA-mediated phagocytosis of immune complexes via the IgA FcαRI receptor on liver Kupfer 
cells (van Egmond et al. 2000). It may be speculated that ω-5 gliadin-specific IgA antibodies 
could have a role in the removal of antigen from the circulation in WDEIA. The distribution 
of IgG subclass antibodies to ω-5 and crude gliadin showed no statistically significant 
differences between the two groups. Mean antibody levels in all four IgG subclasses were 
higher to crude gliadin than to ω-5 gliadin, most likely reflecting a normal immune response 
to dietary antigens. 
 
9.5 Allergens in rye and barley cross-reacting with ω-5 gliadin  
Varjonen et al. (1997) showed in five patients with WDEIA IgE binding to prolamins of rye, 
barley, and oats. Because of possible cross-reactivity between wheat and these taxonomically 
related cereals, patients with WDEIA have been treated with a gluten-free diet. Study II 
characterized two rye allergens (γ-70 and γ-35 secalins) and one barley allergen (γ-3 hordein) 
cross-reacting with ω-5 gliadin. Over 80% of the patient sera showed IgE binding to these 
purified allergens in ELISA. The finding that ω-5 gliadin (100 µg/ml) inhibited over 90% of 
the IgE binding to solid-phase γ-secalins and γ-hordein, but crosswise inhibitions with these 
allergens only about 50% of the IgE binding to solid-phase ω-5 gliadin, suggests that IgE 
antibodies bind to ω-5 gliadin with a greater affinity (Aalberse et al. 2001). In other words, 
the stability of the ω-5 gliadin-IgE complex seems higher than that of the γ-secalin or γ-
hordein-IgE complex. However, differences in the number of IgE-binding epitopes in the 
allergens may as well contribute to the degree of inhibition (Berzofsky and Schechter 1981). 
ω-5 gliadin elicited positive SPT responses at a lower concentration than the γ-secalins or γ-3 
hordein, proposing that among these proteins ω-5 gliadin is the primary sensitizing allergen 
(Aalberse et al. 2001). Taken together, it is likely that γ-70 secalin, γ-35 secalin and γ-3 
hordein contain IgE-binding epitopes structurally similar to those in ω-5 gliadin. 
 
The clinical significance of the cross-reactive rye and barley allergens is uncertain. There 
seems to be individual variation in the sensitivity of the patients. Some patients have reported 
symptoms when exercising after rye ingestion, while others have been able to ingest rye and 
barley without problems. However, because of the severe and potentially life-threatening 
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nature of the reactions, avoidance of rye and barley seems reasonable in patients with 
WDEIA. Moreover, repeated exposure to cross-reactive allergens could lead to further 
sensitization (Aalberse et al. 2001), thereby increasing the risk of anaphylaxis in the future. 
Oats, which have a considerably lower prolamin content than wheat, rye, or barley, did not 
reveal allergens cross-reacting with ω-5 gliadin. Oats belong to a separate tribe in the grass 
family and are therefore more distantly related to wheat (Shewry and Miflin 1985). After 
Study II, most patients have reintroduced oats into their diet, and no symptoms have appeared 
after oats ingestion. Similarly, oats ingestion caused no harm for celiac patients in a recent 
five-year follow-up study (Janatuinen et al. 2002). 
 
9.6 Cellular immune responses to gliadin in WDEIA 
Stimulation with ω-5 or crude gliadin induced high histamine release from the basophils of 
patients with WDEIA. This supports the clinical significance of ω-5 gliadin as a major 
allergen and the central role of IgE antibodies in the pathogenesis of WDEIA. Stimulation of 
PBMC with gliadin elicited enhanced proliferative responses in patients with WDEIA as well 
as significantly decreased expression of IL-10 mRNA, suggesting aberrant regulation of cell-
mediated immune responses to gliadin in these patients. 
 
Recent evidence proposes a central role for IL-10 in an anti-inflammatory network that 
balances the expression of Th1 and Th2 immune responses (Barnes 2001, Yazdanbakhsh et 
al. 2002). Among many of its functions, IL-10 suppresses antigen-specific T cell activation, 
proliferation, and cytokine production (Barnes 2001). Activation of T cells in the presence of 
IL-10 induces anergy, a state of unresponsiveness mainly characterized by suppressed 
proliferation and cytokine production (Groux et al. 1996). Furthermore, IL-10 is required in 
the induction of protective oral tolerance, i.e., systemic unresponsiveness to ingested protein 
antigens, a mechanism that is considered important in controlling the development of food 
allergies (Rizzo et al. 1999). It may thus be hypothesized that impaired IL-10 production in 
patients with WDEIA in response to gliadin stimulation could explain their enhanced 
proliferative responses, whereas in healthy individuals, cellular responses to gliadin could be 
controlled by IL-10.  
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9.7 A hypothesis for the mechanism of WDEIA 
The pathophysiologic mechanisms underlying FDEIA are poorly understood. It remains 
unknown, why both exercise and specific IgE antibodies are needed to provoke symptoms. 
Study V proposes that tTG, a stress-responsive enzyme in the gastrointestinal mucosa, could 
be activated during physical exercise in patients with WDEIA, and that tTG-mediated cross-
linking could enhance the IgE-binding ability of ingested ω-5 gliadin peptides.  
 
Study V showed that the IgE-binding ability of ω-5 gliadin is retained after pepsin and trypsin 
digestion, which is a characteristic property of food allergens (Astwood et al. 1996). tTG 
treatment of pepsin-digested ω-5 gliadin created high-molecular-weight complexes that 
intensely bound IgE in the sera of patients with WDEIA. The structure of these IgE-binding 
complexes was not studied, but in all likelihood, they consisted of ω-5 gliadin peptides cross-
linked to each other and to tTG itself (Molberg et al. 1998). Cross-linking of a purified peptic 
fraction of ω-5 gliadin led to enhanced IgE reactivity, both in vitro and in vivo. The 
significant increase in the mean SPT wheal area after tTG treatment suggests that 
incorporation of the IgE-binding epitopes into large complexes favors the degranulation of 
IgE-sensitized mast cells. The in vitro finding that intact ω-5 gliadin inhibited serum IgE 
binding to the tTG-treated peptic fraction, and vice versa, suggests that the IgE-binding 
epitopes in ω-5 gliadin are conserved during digestion and that tTG treatment does not create 
neoepitopes. However, their altered spatial arrangement could explain the significantly 
enhanced SPT responses. Namely, it is possible that these highly stable aggregates (Chen and 
Mehta 1999) of allergen peptides complexed with tTG could cross-link IgE molecules, bound 
to high affinity receptors on mast cells, more effectively than the same amount of IgE 
epitopes present on individual peptides of smaller size. 
 
In a recent study on celiac disease, Shan et al. (2002) isolated a 33-amino acid peptide from 
α-gliadin that was highly stable to all gastrointestinal digestive enzymes. It contained six 
previously identified antigenic T-cell epitopes and was a potent inducer of intestinal T cell 
lines of celiac patients. Moreover, deamidation of this peptide by tTG led to enhanced T cell 
stimulation. Homologous peptide sequences were found in all cereal grains toxic in celiac 
disease, i.e., wheat, rye, and barley, but not in non-toxic grains, such as oats and rice. Whether 
similar resistant sequences are present in ω-5 gliadin remains to be elucidated, as the full 
amino acid sequence of this protein is still unknown. However, IgE reactivity to α-gliadin in 
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patients with WDEIA was low or absent (I), suggesting that different gliadin peptides are 
involved in the pathogenesis of this allergy. 
 
Under normal physiological conditions tTG exists as a latent intracellular enzyme that is 
inactive in regard to protein cross-linking (Smethurst and Griffin 1996). The enzyme is 
released and activated under stress-like conditions, e.g., inflammation, infection, oxidative 
and metabolic stress (Kim et al. 2002). In celiac disease, increased tTG activity seems to be 
related to chronic inflammation and mucosal damage (Sollid 2002). Although no direct 
evidence of tTG activation in response to exercise exists, many factors released during 
exercise are known to activate this stress-responsive enzyme.  
 
Physical exercise has been introduced as a model for the stress response. It elicits a 
subclinical inflammatory response, characterized by a rapid rise in plasma concentrations of 
the pro-inflammatory cytokines TNF-α and IL-1β, followed by a dramatic increase in the 
inflammation-responsive cytokine IL-6 (Ostrowski et al. 1999). Exercise increases production 
of glucocorticoid stress hormones (Pedersen and Hoffmann-Goetz 2000) and reactive oxygen 
species, and intense exercise can lead to oxidative stress (Cooper et al. 2002). Moreover, 
strenuous exercise reduces splanchnic blood flow up to 50% (Qamar and Read 1987), which 
may cause gastric mucosal ischemia and increased permeability (Pals et al. 1997, Otte et al. 
2001). In summary, evidence exists that tTG can be activated by TNF-α and IL-6, 
glucocorticoid hormones and reactive oxygen species (Suto et al. 1993, Mirza et al. 1997, 
Johnson et al. 1998, Kuncio et al. 1998), all of which are detectable in an exercising 
individual. Furthermore, severe or prolonged exercise may lead to intestinal ischemia and 
cellular damage. It is thus reasonable to speculate that the cross-linking function of tTG could 
be activated in response to physical exercise.  
 
In conclusion, the findings in Study V together with current knowledge on tTG activation and 
exercise immunology support the hypothesis that tTG could be activated during physical 
exercise in the intestinal mucosa of patients with WDEIA. This could lead to the formation of 
large allergen complexes with numerous IgE-binding epitopes capable of eliciting 
anaphylactic reactions in patients with WDEIA.  
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9.8 Future directions  
The current study provides new insights into the causative allergens and potential mechanisms 
of WDEIA. ω-5 gliadin, an ethanol-soluble storage protein of the wheat grain, turned out to 
be a major allergen in WDEIA, nevertheless, the clinical significance of other gliadins needs 
further investigation. Future studies should focus on detailed characterization allergens 
involved in childhood wheat allergy. A large amount of work is still required, before the 
clinically significant wheat allergens and their IgE-binding epitopes have been identified. It 
remains to be seen, whether other purified soluble or insoluble wheat proteins give diagnostic 
predictive values similar to those of ω-5 gliadin. Furthermore, the full amino acid sequence, 
IgE-binding epitopes, and tertiary structure of ω-5 gliadin remain to be identified.  
 
Further in vivo studies demonstrating the presence of gliadin-tTG complexes in the circulation 
or intestinal mucosa of patients with WDEIA are needed to confirm the hypothesis proposed 
in Study V. This rather demanding approach is not without risks and limitations; in order to 
detect such complexes, wheat and exercise challenges should be continued until the induction 
of anaphylaxis. A safer approach would be the detection of ω-5 gliadin-tTG complexes in 
non-allergic individuals, however, it is possible that such complexes are not formed in healthy 
persons. An alternative possibility would be to study gliadin uptake and tTG activity in 
intestinal cultures from patients with WDEIA.  
 
Another future aim is to examine, whether tTG can cross-link allergens from foods other than 
wheat. However, no other allergens capable of eliciting FDEIA have been isolated and 
characterized thus far. Detailed characterization of the ω-5 gliadin peptides cross-linked by 
tTG could be helpful in predicting the allergenic potential of other cereal proteins. The 
possible role of tTG-mediated cross-linking in children with IgE to ω-5 gliadin needs as well 
further investigation. 
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10. CONCLUSIONS 
 
The series of 32 patients with WDEIA reported in this study suggests that the prevalence of 
this disorder may be higher than generally assumed, and that WDEIA is a poorly recognized 
form of allergy. This study was the first to identify, purify and characterize clinically 
significant wheat allergens involved in WDEIA. It demonstrated that ω-5 gliadin is a major 
allergen in these patients and that cross-reactive allergens are present in rye and barley, but 
not in oats (I, II). This supports the clinical practice of a gluten-free diet, however oats do not 
seem harmful for patients with WDEIA. SPT with crude gliadin is a useful screening method 
for WDEIA, while SPT or ELISA with ω-5 gliadin can be used in the specific diagnosis of 
this severe food allergy. IgE-testing with purified γ-secalins from rye and γ-3 hordein from 
barley may be helpful in individual dietary planning. 
 
There are no previous studies comparing the results of oral wheat challenges in young 
children to IgE reactivity against a purified and well-characterized wheat allergen. The 
presence of IgE antibodies to purified ω-5 gliadin in ELISA or a positive SPT invariably 
associated with immediate symptoms on oral wheat challenge, giving a diagnostic specificity 
and positive predictive value of 100% for immediate challenge reactions (III). Detection of ω-
5 gliadin-specific IgE may be useful in reducing the need for oral wheat challenges, especially 
in children at high risk for serious reactions.  
 
The route of sensitization appears important in the development of wheat allergy. While IgE 
antibodies to ω-5 gliadin were associated with immediate-type allergy to ingested wheat, IgE 
from patients with inhalant wheat allergy did not recognize this allergen. Patients with baker's 
asthma are mostly sensitized to inhaled raw flour particles via the respiratory mucosa, in 
contrast to patients with ingested allergy, who are primarily sensitized to heat-treated and 
digested wheat proteins absorbed through the gastrointestinal epithelium. This could explain 
the apparent differences in sensitization to various allergens, and the finding that most 
patients with baker's asthma tolerate ingested wheat. 
 
Several new findings described in the present study may be helpful in understanding the 
pathophysiologic events in WDEIA. An IgE-mediated immune mechanism is obvious, 
however, unbalanced cell-mediated responses to gliadin, presenting as enhanced PBMC 
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proliferation and downregulated IL-10 expression, seem to play a role. This is in agreement 
with studies highlighting the importance of IL-10 in the regulation of allergic responses. 
Treatment of a purified peptic fraction of ω-5 gliadin with tTG led to a significant increase in 
the in vitro and in vivo IgE reactivity of patients with WDEIA. These findings, together with 
current knowledge on exercise immunology and tTG activation, propose a hypothesis that 
tTG could be activated in response to physical exercise. Cross-linking of ingested ω-5 gliadin 
peptides by tTG could form high-molecular-weight complexes with numerous IgE-binding 
epitopes; these large allergen complexes could trigger anaphylactic reactions in patients with 
WDEIA. 
 
A large amount of work is needed before the clinically significant wheat allergens and their 
IgE-binding epitopes have been identified. Detailed knowledge on the structure and properties 
of major wheat allergens, as well as better understanding of the mechanisms leading to wheat 
allergy and WDEIA, is needed to develop improved strategies for the diagnosis and treatment 
of these diseases.  
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